syndrome	score	normalized_score
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	100.0
EHLERS-DANLOS SYNDROME, TYPE I	1.30008814	65.004407
COFFIN-SIRIS SYNDROME 1; CSS1	1.1200831800000002	56.00415900000001
DIGEORGE SYNDROME; DGS	1.0168114600000002	50.84057300000001
MOWAT-WILSON SYNDROME; MOWS	1.01428046	50.714023
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	1.00847458	50.423728999999994
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.00537634	50.268817
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	1.00223445	50.1117225
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	1.00124533	50.0622665
DUPLICATION OF THE PITUITARY GLAND	1.00098912	50.049456000000006
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	1.0	50.0
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	1.0	50.0
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	50.0
CHIARI MALFORMATION TYPE II	1.0	50.0
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.84180758	42.090379
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.84037525	42.0187625
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.65470597	32.7352985
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.59903918	29.951959
XYLT1-CDG	0.53449406	26.724702999999998
FIBULAR HEMIMELIA	0.5277778	26.388889999999996
CLUSTER HEADACHE, FAMILIAL	0.5277778	26.388889999999996
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.5276555500000001	26.382777500000003
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.5273268099999999	26.366340499999996
BRANCHIOSKELETOGENITAL SYNDROME	0.51591388	25.795694
BECKWITH-WIEDEMANN SYNDROME	0.51584318	25.792158999999998
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.5148778799999999	25.743893999999994
MOSAIC TRISOMY 1	0.51166797	25.583398499999998
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.50980392	25.490195999999997
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.50537634	25.268817
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.50502513	25.251256500000004
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.5046791599999999	25.233957999999994
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.50371447	25.1857235
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.50124533	25.062266500000003
RESTRICTIVE DERMOPATHY	0.50098912	25.049456
TRIGEMINAL NEURALGIA	0.5	25.0
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.5	25.0
MANDIBULOACRAL DYSPLASIA	0.5	25.0
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.5	25.0
SPONDYLOPERIPHERAL DYSPLASIA	0.5	25.0
THUMB, DISTAL HYPEREXTENSIBILITY OF	0.5	25.0
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.46907812000000004	23.453906000000003
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.43333299999999997	21.666649999999997
WILLIAMS-BEUREN SYNDROME; WBS	0.38623252999999996	19.3116265
8Q24.3 MICRODELETION SYNDROME	0.38009035	19.004517500000002
OSGOOD-SCHLATTER DISEASE	0.366667	18.33335
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.36213382	18.106691
7Q11.23 MICRODUPLICATION SYNDROME	0.35491438000000003	17.745719
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.35	17.5
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.34929021	17.4645105
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34542639999999997	17.27132
EPISODIC ATAXIA TYPE 1	0.34516094999999997	17.2580475
AYME-GRIPP SYNDROME; AYGRP	0.34262520999999996	17.131260499999996
SILVER-RUSSELL SYNDROME; SRS	0.33982650999999997	16.9913255
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.33870933999999997	16.935467
GABRIELE-DE VRIES SYNDROME	0.33812007	16.9060035
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33686657	16.8433285
CLEIDOCRANIAL DYSPLASIA	0.33604626	16.802312999999998
TREACHER-COLLINS SYNDROME	0.33556745	16.7783725
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	16.7289165
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.333333	16.66665
%109500 BASILAR IMPRESSION, PRIMARY	0.333333	16.66665
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.66665
GLYCOGEN STORAGE DISEASE IB	0.333333	16.66665
PLACENTAL INSUFFICIENCY	0.333333	16.66665
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.333333	16.66665
CLEFT VELUM	0.333333	16.66665
GLYCOGEN STORAGE DISEASE IA	0.333333	16.66665
OSTEOGENESIS IMPERFECTA, TYPE V	0.33327914000000003	16.663957
WIEDEMANN-STEINER SYNDROME	0.32106067	16.053033499999998
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.32071709	16.0358545
TRICHOTHIODYSTROPHY	0.3154664100000001	15.773320500000004
MELNICK-NEEDLES SYNDROME	0.28556775000000006	14.278387500000003
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.26127036	13.063517999999998
SHEEHAN SYNDROME	0.25747768	12.873883999999999
PITUITARY APOPLEXY	0.25	12.5
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	12.5
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.5
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	12.5
UVEAL MELANOMA	0.25	12.5
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.25	12.5
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	12.5
HYPERPARATHYROIDISM 2	0.25	12.5
DYSTONIA 6, TORSION	0.25	12.5
ALLAN-HERNDON-DUDLEY SYNDROME	0.25	12.5
WILLIAMS SYNDROME	0.24152261	12.0761305
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.22857143000000002	11.4285715
PUDENDAL NEURALGIA	0.22857143000000002	11.4285715
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.22783352	11.391676
HYPERCALCEMIA, INFANTILE, 1	0.2208333	11.041665
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.22	11.0
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.2185185	10.925925
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.21837361000000002	10.9186805
FILIPPI SYNDROME; FLPIS	0.21785710000000003	10.892855
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.21520453000000003	10.760226500000002
RARE CIRCULATORY SYSTEM DISEASE	0.214286	10.7143
KAGAMI-OGATA SYNDROME	0.21369893	10.6849465
COHEN SYNDROME	0.21080247000000002	10.540123500000002
KAGAMI-OGATA SYNDROME	0.21012750000000002	10.506375000000002
AYMÉ-GRIPP SYNDROME	0.20929221000000003	10.464610500000001
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.20868515	10.434257500000001
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.20833333	10.4166665
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20813008000000002	10.406504000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.20793532000000003	10.396766000000001
HEMIFACIAL MICROSOMIA	0.20765559	10.3827795
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.20748263000000003	10.3741315
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	10.212411000000001
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.20395859000000002	10.1979295
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.20223445	10.1117225
600736 VELOFACIOSKELETAL SYNDROME	0.20098912000000002	10.049456000000001
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.2	10.0
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.2	10.0
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.2	10.0
PATELLA, CHONDROMALACIA OF	0.2	10.0
CAYLER CARDIOFACIAL SYNDROME	0.2	10.0
PORPHYRIA, ACUTE HEPATIC	0.2	10.0
ROMANO-WARD SYNDROME	0.2	10.0
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.2	10.0
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	10.0
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.2	10.0
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.2	10.0
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.2	10.0
CRYPTOSPORIDIOSIS	0.2	10.0
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.2	10.0
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.2	10.0
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.2	10.0
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	10.0
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.19482754	9.741377
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	9.722215
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	9.722215
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	9.722215
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	9.722215
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	9.722215
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	9.722215
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	9.722215
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.19396465	9.6982325
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18903241	9.4516205
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.17594959000000002	8.797479500000001
FRYNS SYNDROME; FRNS	0.17118969000000003	8.559484500000002
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.16839114000000002	8.419557000000001
GANGLIONEUROMA	0.16785699999999998	8.39285
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.166667	8.333350000000001
SINDING-LARSEN-JOHANSSON DISEASE	0.166667	8.333350000000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.166667	8.333350000000001
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.166667	8.333350000000001
PELVIS-SHOULDER DYSPLASIA	0.166667	8.333350000000001
LARON SYNDROME	0.16666660000000003	8.333330000000002
KENNERKNECHT SYNDROME	0.16394644000000003	8.197322000000002
POSTERIOR CORTICAL ATROPHY	0.1637426	8.18713
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.1637426	8.18713
SMITH-MAGENIS SYNDROME; SMS	0.16126042000000002	8.063021
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.16103879999999998	8.051939999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.15858971	7.9294855
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.15677496999999999	7.8387484999999995
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.15552964	7.776482
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.15477308999999997	7.738654499999999
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.15467711999999997	7.7338559999999985
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.15162339	7.5811695
CHILDHOOD ABSENCE EPILEPSY	0.14900518000000001	7.450259000000001
PHACE SYNDROME	0.14410232999999997	7.205116499999999
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	7.142849999999999
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	7.142849999999999
AUTOIMMUNE HYPOPARATHYROIDISM	0.14285699999999998	7.142849999999999
MYOPATHIC EHLERS-DANLOS SYNDROME	0.13580247	6.7901235
DISTAL 16P11.2 MICRODELETION SYNDROME	0.13191975	6.5959875
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.13100271	6.5501355
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.12903989999999999	6.451994999999999
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.12746914	6.373457
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.12723445	6.3617225
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.12723445	6.3617225
ULBRIGHT-HODES SYNDROME	0.12672414	6.336207000000001
PETERS-PLUS SYNDROME; PTRPLS	0.12663664	6.3318319999999995
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.125	6.25
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.125	6.25
RENAL AGENESIS	0.125	6.25
NON-FUNCTIONING PARAGANGLIOMA	0.125	6.25
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.125	6.25
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.125	6.25
17Q24.2 MICRODELETION SYNDROME	0.12475570999999999	6.237785499999999
TURCOT SYNDROME WITH POLYPOSIS	0.12419099999999998	6.209549999999999
DUBOWITZ SYNDROME	0.12315264000000002	6.157632000000001
CHROMOSOME 16P13.3 DELETION SYNDROME	0.12242175999999999	6.121087999999999
OKAMOTO SYNDROME	0.12215758999999998	6.107879499999999
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.1208333	6.041665
ZIMMERMANN-LABAND SYNDROME	0.12043344999999998	6.021672499999999
WARBURG MICRO SYNDROME 1	0.11944432999999999	5.972216499999999
TRISOMY 18	0.11847163000000001	5.9235815
NORMAL PRESSURE HYDROCEPHALUS	0.1172249	5.861245
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1172249	5.861245
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.11636870999999999	5.8184355
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.11565533	5.7827665
45,X/46,XY MIXED GONADAL DYSGENESIS	0.11501724999999999	5.750862499999999
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11382425999999998	5.691212999999999
W SYNDROME	0.11382425999999998	5.691212999999999
MALAN OVERGROWTH SYNDROME	0.11350595000000001	5.6752975
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.11345251	5.6726255000000005
ADRENOCORTICAL CARCINOMA	0.11289843000000001	5.644921500000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.11283513999999999	5.641756999999999
OROMANDIBULAR DYSTONIA	0.11111110000000002	5.555555000000001
PORPHYRIA CUTANEA TARDA	0.11111099999999999	5.555549999999999
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.11111099999999999	5.555549999999999
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.11111099999999999	5.555549999999999
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	5.555549999999999
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	5.555549999999999
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	5.555549999999999
FACIAL HYPERTRICHOSIS	0.11111099999999999	5.555549999999999
COG8-CDG	0.11111099999999999	5.555549999999999
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.11111099999999999	5.555549999999999
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	5.555549999999999
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.11111099999999999	5.555549999999999
PAROXYSMAL HEMICRANIA	0.10980392	5.490196
CARNEY COMPLEX	0.10813008	5.406504
CHRISTIANSON SYNDROME	0.10680394000000001	5.340197000000001
RHIZOMELIC SYNDROME, URBACH TYPE	0.10489874	5.244937
SAGLIKER SYNDROME	0.10369004000000001	5.184502
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.10318216000000001	5.159108000000001
POLAND SYNDROME	0.10246914	5.123457
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.10246273	5.1231365
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.10110009	5.0550045
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.10057470000000002	5.028735000000001
HELLP SYNDROME	0.10041767	5.0208835
LIG4 SYNDROME	0.1	5.0
NAGER SYNDROME	0.1	5.0
KAPOSI SARCOMA	0.1	5.0
PARAGANGLIOMAS 3	0.1	5.0
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.1	5.0
CERNUNNOS-XLF DEFICIENCY	0.1	5.0
GLOMUVENOUS MALFORMATION	0.1	5.0
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	5.0
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.1	5.0
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	5.0
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.1	5.0
METAPHYSEAL ANADYSPLASIA	0.1	5.0
PARAGANGLIOMAS 1	0.1	5.0
PSEUDOPROGERIA SYNDROME	0.1	5.0
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.1	5.0
PARAGANGLIOMAS 4	0.1	5.0
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	5.0
PRADER-WILLI SYNDROME; PWS	0.09978290999999999	4.989145499999999
INSULIN-RESISTANCE SYNDROME TYPE B	0.09903918	4.951959
CHARGE SYNDROME	0.09830848	4.915424
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.09738996000000001	4.869498000000001
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.09628544	4.814272
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.09546965	4.7734825
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.09544160000000002	4.772080000000001
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.09544160000000002	4.772080000000001
HEPATIC VENO-OCCLUSIVE DISEASE	0.09504133000000001	4.752066500000001
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.09504133000000001	4.752066500000001
PRADER-WILLI-LIKE SYNDROME	0.09497182	4.748591
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.09462357	4.7311785
SPINOCEREBELLAR ATAXIA TYPE 13	0.09459914000000001	4.729957000000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.09432230000000001	4.716115
PRADER-WILLI SYNDROME	0.09377456	4.688728
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.09238139000000001	4.6190695
ZIMMERMANN-LABAND SYNDROME 1	0.09212813	4.6064065
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.09210523000000001	4.6052615
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0909091	4.5454550000000005
STUVE-WIEDEMANN SYNDROME	0.0909091	4.5454550000000005
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0909091	4.5454550000000005
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0909091	4.5454550000000005
INSULINOMA	0.0909091	4.5454550000000005
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.0909091	4.5454550000000005
WILSON DISEASE	0.0909091	4.5454550000000005
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0909091	4.5454550000000005
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0909091	4.5454550000000005
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0909091	4.5454550000000005
MENTAL RETARDATION, X-LINKED 2	0.0909091	4.5454550000000005
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.09090137000000001	4.5450685
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.08895943	4.4479715
POSTORGASMIC ILLNESS SYNDROME	0.08870964	4.435482
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.08802876000000001	4.401438000000001
RAMOS-ARROYO SYNDROME	0.08768066000000001	4.3840330000000005
MUCKLE-WELLS SYNDROME	0.08746553000000001	4.373276500000001
SARCOSINEMIA	0.08613503	4.3067515
CAMPOMELIC DYSPLASIA	0.08604656000000001	4.302328
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.08556775000000001	4.278387500000001
2Q24 MICRODELETION SYNDROME	0.08432242000000001	4.216121
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.08432242000000001	4.216121
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.08432242000000001	4.216121
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.08396535000000001	4.1982675
SMITH-MAGENIS SYNDROME	0.08356973	4.1784865
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.08337471	4.1687355
THANATOPHORIC DYSPLASIA, TYPE II	0.08333330000000001	4.166665000000001
THANATOPHORIC DYSPLASIA, TYPE I	0.08333330000000001	4.166665000000001
ALKAPTONURIA	0.08333330000000001	4.166665000000001
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08333330000000001	4.166665000000001
POSTPOLIOMYELITIS SYNDROME	0.08333330000000001	4.166665000000001
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	4.166665000000001
SILLENCE SYNDROME	0.08333330000000001	4.166665000000001
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.08333330000000001	4.166665000000001
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.08333330000000001	4.166665000000001
WARSAW BREAKAGE SYNDROME; WABS	0.08333330000000001	4.166665000000001
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08333330000000001	4.166665000000001
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.08333330000000001	4.166665000000001
ERMINE PHENOTYPE	0.08333330000000001	4.166665000000001
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	4.166665000000001
CORACOCLAVICULAR JOINT, ANOMALOUS	0.08333330000000001	4.166665000000001
SCLEROSTEOSIS	0.08333330000000001	4.166665000000001
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.08333330000000001	4.166665000000001
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.08333330000000001	4.166665000000001
BOWEN-CONRADI SYNDROME	0.08333330000000001	4.166665000000001
METACHONDROMATOSIS	0.08333330000000001	4.166665000000001
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	4.166665000000001
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.08333330000000001	4.166665000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.08333330000000001	4.166665000000001
DIPROSOPUS	0.08333330000000001	4.166665000000001
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.08205593	4.1027965
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.08076221	4.0381105
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0804094	4.02047
GRANT SYNDROME	0.07974803	3.9874015
RHEUMATIC FEVER	0.07891110999999999	3.9455554999999998
CHROMOSOME 2Q37 DELETION SYNDROME	0.07760976	3.880488
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.07694627	3.8473135
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07692310000000001	3.8461550000000004
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.07692310000000001	3.8461550000000004
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.07692310000000001	3.8461550000000004
HURLER SYNDROME	0.07658121	3.8290604999999998
NEUROFIBROMATOSIS TYPE 1	0.07531716999999999	3.7658584999999993
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.07420415999999999	3.7102079999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.07320018	3.660009
COFFIN-LOWRY SYNDROME; CLS	0.07214169000000001	3.6070845000000005
COSTELLO SYNDROME	0.07153772	3.576886
NOONAN SYNDROME	0.07049474	3.524737
CARTILAGE-HAIR HYPOPLASIA	0.07047329000000001	3.5236645
LOEYS-DIETZ SYNDROME 5	0.06990318000000001	3.4951590000000006
MENTAL RETARDATION, X-LINKED 97; MRX97	0.06986332	3.4931660000000004
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.06955509	3.4777545
SCHWARTZ-JAMPEL SYNDROME	0.06924702	3.4623510000000004
AARSKOG-SCOTT SYNDROME	0.06857136	3.428568
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.06704115	3.3520575
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.06699316999999999	3.3496584999999994
DISTAL MONOSOMY 7Q36	0.06664778	3.332389
CRI-DU-CHAT SYNDROME	0.06633398000000001	3.3166990000000007
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.06540245	3.2701225000000003
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.06523376	3.261688
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.06503468	3.251734
COSTELLO SYNDROME; CSTLO	0.06351452	3.175726
ASPARTYLGLUCOSAMINURIA	0.06334619	3.1673095
ADNP SYNDROME	0.063249	3.1624499999999998
20Q11.2 MICRODUPLICATION SYNDROME	0.06282777	3.1413885
NIJMEGEN BREAKAGE SYNDROME	0.06274422	3.137211
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.06259785000000001	3.1298925000000004
STORMORKEN SYNDROME; STRMK	0.06243552	3.121776
ALEXANDER DISEASE	0.06239493	3.1197465
ISOLATED CEREBELLAR AGENESIS	0.06230663	3.1153315
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.06188098000000001	3.0940490000000005
RECOMBINANT 8 SYNDROME	0.06153676	3.076838
BASAL CELL NEVUS SYNDROME	0.06132362000000001	3.0661810000000003
BILATERAL POLYMICROGYRIA	0.06110618	3.0553090000000003
ASPARTYLGLUCOSAMINURIA; AGU	0.06081331	3.0406655000000002
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.06054764	3.027382
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.060068830000000004	3.0034415
CEREBROOCULONASAL SYNDROME	0.059812620000000004	2.990631
RECOMBINANT CHROMOSOME 8 SYNDROME	0.05951419000000001	2.9757095000000002
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.059461850000000004	2.9730925000000004
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.05943912	2.971956
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.05924564	2.962282
PACHYDERMOPERIOSTOSIS	0.05908917	2.9544585000000003
CRISPONI SYNDROME	0.0588235	2.941175
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.058645850000000006	2.9322925000000004
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.058024740000000005	2.901237
H SYNDROME	0.0578571	2.892855
PIERPONT SYNDROME	0.05779005000000001	2.8895025000000003
SCHEIE SYNDROME	0.05727974	2.8639870000000003
STEINERT MYOTONIC DYSTROPHY	0.056800930000000006	2.8400465
ELLIS VAN CREVELD SYNDROME	0.056800930000000006	2.8400465
DISTAL TRISOMY 6P	0.056800930000000006	2.8400465
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.05654472000000001	2.8272360000000005
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.05654472000000001	2.8272360000000005
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.05603007	2.8015035
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.05602236	2.801118
CORNELIA DE LANGE SYNDROME	0.05570129000000001	2.7850645000000003
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	2.7777800000000004
DERMATOMYOSITIS	0.055555600000000004	2.7777800000000004
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.055555600000000004	2.7777800000000004
BAMFORTH-LAZARUS SYNDROME	0.055555600000000004	2.7777800000000004
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.055555600000000004	2.7777800000000004
HOLOPROSENCEPHALY 7	0.055555600000000004	2.7777800000000004
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	2.7777800000000004
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	2.7777800000000004
MARFANOID HABITUS WITH SITUS INVERSUS	0.055113270000000006	2.7556635000000003
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.055111160000000006	2.755558
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.0548193	2.740965
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.05435982	2.717991
TUFTED ANGIOMA	0.05410948000000001	2.7054740000000006
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.0540223	2.701115
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.05376639	2.6883195
CHROMOSOME 10Q26 DELETION SYNDROME	0.05375358000000001	2.6876790000000006
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.0526316	2.63158
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0526316	2.63158
ADULT-ONSET DYSTONIA-PARKINSONISM	0.0526316	2.63158
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.0526316	2.63158
DYSLEXIA, SUSCEPTIBILITY TO, 8	0.0526316	2.63158
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.0526316	2.63158
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.0526316	2.63158
DYSLEXIA, SUSCEPTIBILITY TO, 2	0.0526316	2.63158
SEMANTIC DEMENTIA	0.0526316	2.63158
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.052500000000000005	2.6250000000000004
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.052500000000000005	2.6250000000000004
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.05130904	2.565452
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.05124673	2.5623365
SPONDYLO-OCULAR SYNDROME	0.04966944	2.483472
16P13.2 MICRODELETION SYNDROME	0.04951004	2.475502
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.04928377	2.4641884999999997
MESOMELIA-SYNOSTOSES SYNDROME	0.048962649999999996	2.4481325
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.048608120000000005	2.430406
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.048608120000000005	2.430406
MICROPHTHALMIA WITH LIMB ANOMALIES	0.047935320000000003	2.3967660000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.047887940000000004	2.394397
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.04770366	2.385183
GENOCHONDROMATOSIS TYPE 1	0.047619	2.38095
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.047619	2.38095
MYCETOMA	0.047619	2.38095
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.047619	2.38095
PIGMENTED VILLONODULAR SYNOVITIS	0.047619	2.38095
POPLITEAL CYST	0.047619	2.38095
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.047619	2.38095
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.047619	2.38095
BLOUNT DISEASE	0.047619	2.38095
HEMIMELIA	0.047619	2.38095
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.047619	2.38095
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.047619	2.38095
GERODERMA OSTEODYSPLASTICUM; GO	0.047619	2.38095
CRANIO-OSTEOARTHROPATHY	0.047619	2.38095
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.047619	2.38095
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.047619	2.38095
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.047619	2.38095
OSTEOCHONDRITIS DISSECANS	0.047619	2.38095
CUSHING DISEASE	0.04756932	2.378466
TRIOPIA	0.047399380000000005	2.369969
CENTRAL CONGENITAL HYPOTHYROIDISM	0.047105	2.35525
ACROMICRIC DYSPLASIA	0.04704225	2.3521125
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.04697165	2.3485825
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04586674	2.293337
MOWAT-WILSON SYNDROME	0.04580588	2.290294
POEMS SYNDROME	0.045634900000000006	2.2817450000000004
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.04534450000000001	2.2672250000000007
CLASSICAL EHLERS-DANLOS SYNDROME	0.04437011	2.2185055
CURRY-JONES SYNDROME	0.04395214	2.197607
RENPENNING SYNDROME 1; RENS1	0.04375297	2.1876485
SIALURIA	0.043320500000000005	2.1660250000000003
CUSHING SYNDROME	0.042192980000000005	2.109649
16P12.1P12.3 TRIPLICATION SYNDROME	0.04212432	2.106216
PITT-HOPKINS-LIKE SYNDROME	0.04191926	2.095963
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04172414	2.086207
WITTEVEEN-KOLK SYNDROME	0.04160166	2.080083
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0414968	2.07484
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.04141597	2.0707985
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.04128654	2.064327
LESCH-NYHAN SYNDROME	0.041030029999999995	2.0515014999999996
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	2.0515014999999996
HUNTINGTON DISEASE	0.041030029999999995	2.0515014999999996
DIENCEPHALIC SYNDROME	0.041030029999999995	2.0515014999999996
NEURONAL CEROID LIPOFUSCINOSIS	0.041030029999999995	2.0515014999999996
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.04100125	2.0500625
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.040902810000000005	2.0451405
611426 TENTED EYEBROWS	0.0408333	2.041665
INFANTILE MYOFIBROMATOSIS	0.0408333	2.041665
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.04031489	2.0157445
ROMBO SYNDROME	0.04	2.0
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	2.0
DYSKERATOSIS CONGENITA	0.04	2.0
PILI TORTI	0.04	2.0
ULERYTHEMA OPHRYOGENESIS	0.04	2.0
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.04	2.0
ACRODERMATITIS ENTEROPATHICA	0.04	2.0
MONILETHRIX	0.04	2.0
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	2.0
GRISCELLI SYNDROME	0.04	2.0
VOGT-KOYANAGI-HARADA DISEASE	0.04	2.0
BÖÖK SYNDROME	0.04	2.0
FETAL ALCOHOL SYNDROME	0.039957870000000006	1.9978935000000004
TURNPENNY-FRY SYNDROME; TPFS	0.03990141	1.9950705
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	1.98506
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.039423330000000006	1.9711665000000003
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0393518	1.96759
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.03926545	1.9632725
DESBUQUOIS DYSPLASIA 2; DBQD2	0.03924018	1.962009
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.03921834	1.9609169999999998
HYPERTRICHOSIS CUBITI	0.038615300000000005	1.9307650000000003
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.038530999999999996	1.9265499999999998
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.03848042	1.924021
RIN2 SYNDROME	0.038178779999999995	1.9089389999999997
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.9037350000000002
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.038060750000000004	1.9030375000000002
ALSTRÖM SYNDROME	0.038060750000000004	1.9030375000000002
ACTH-INDEPENDENT CUSHING SYNDROME	0.038060750000000004	1.9030375000000002
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.038060750000000004	1.9030375000000002
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.03774513	1.8872565000000001
EPENDYMOMA	0.03758172	1.879086
SUBEPENDYMOMA	0.03758172	1.879086
PROTEUS SYNDROME	0.03740536999999999	1.8702684999999997
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.03720732	1.8603660000000002
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.03715064	1.857532
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.03715064	1.857532
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.037115459999999996	1.855773
TEMPLE SYNDROME	0.03697933	1.8489665
DISTAL MONOSOMY 10Q	0.03693769	1.8468845
MELAS	0.03646118	1.8230590000000002
ACROOSTEOLYSIS DOMINANT TYPE	0.036455690000000006	1.8227845000000003
15Q24 MICRODELETION SYNDROME	0.0363345	1.816725
SOMATOMAMMOTROPINOMA	0.03623896	1.8119480000000001
ACROMEGALY	0.03623896	1.8119480000000001
THUMBS, CONGENITAL CLASPED	0.0361093	1.8054649999999999
BRAIN-LUNG-THYROID SYNDROME	0.035853789999999996	1.7926894999999998
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.035853789999999996	1.7926894999999998
HOLMES-GANG SYNDROME	0.035815099999999996	1.7907549999999999
MUCOPOLYSACCHARIDOSIS TYPE 2	0.03569732	1.7848659999999998
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0354232	1.77116
BLOOM SYNDROME	0.035297709999999996	1.7648854999999999
MARFAN SYNDROME; MFS	0.03529118	1.764559
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03480392	1.740196
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.03479038	1.739519
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.03479038	1.739519
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.03477056	1.7385279999999999
FLYNN-AIRD SYNDROME	0.03472724	1.736362
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.03472724	1.736362
WOLF-HIRSCHHORN SYNDROME	0.034492550000000004	1.7246275000000002
15Q13.3 MICRODELETION SYNDROME	0.03448761	1.7243805
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.03443693	1.7218464999999998
3Q29 MICRODELETION SYNDROME	0.03410005	1.7050025
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.03397235	1.6986175
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.03394777	1.6973885000000002
PRIMARY PARATHYROID HYPERPLASIA	0.03394777	1.6973885000000002
PARATHYROID CARCINOMA	0.03394777	1.6973885000000002
SECKEL SYNDROME 9; SCKL9	0.03387123	1.6935615000000002
NEUROFERRITINOPATHY	0.033619960000000004	1.6809980000000002
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.03350343	1.6751715
LEIGH SYNDROME	0.03350343	1.6751715
PYRIDOXINE-DEPENDENT EPILEPSY	0.03350343	1.6751715
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.03350343	1.6751715
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.03350343	1.6751715
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.03338337	1.6691685
MARFANOID HYPERMOBILITY SYNDROME	0.03333333	1.6666665
OSTEOGENESIS IMPERFECTA, TYPE I	0.03333333	1.6666665
PYRUVATE DEHYDROGENASE DEFICIENCY	0.03325472	1.662736
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.03313008	1.656504
WYBURN-MASON SYNDROME	0.0330632	1.65316
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	1.6491614999999997
300270 ADRENOMYODYSTROPHY	0.032983229999999995	1.6491614999999997
MAN1B1-CDG	0.03286608	1.6433039999999999
22Q11.2 DELETION SYNDROME	0.032864529999999996	1.6432264999999997
48,XXYY SYNDROME	0.03282318	1.641159
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.03276741	1.6383704999999997
HSD10 DISEASE	0.03276741	1.6383704999999997
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.03276741	1.6383704999999997
DESANTO-SHINAWI SYNDROME	0.032503630000000006	1.6251815000000003
FONTAINE PROGEROID SYNDROME; FPS	0.03244021	1.6220104999999998
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.032427700000000004	1.621385
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0323571	1.617855
19P13.12 MICRODELETION SYNDROME	0.03233413	1.6167065
MERRF	0.0322581	1.6129049999999998
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0322581	1.6129049999999998
ATYPICAL RETT SYNDROME	0.0322581	1.6129049999999998
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.6129049999999998
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.6129049999999998
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.6129049999999998
SANDHOFF DISEASE	0.0322581	1.6129049999999998
OXOGLUTARIC ACIDURIA	0.0322581	1.6129049999999998
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.6129049999999998
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.6129049999999998
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0322581	1.6129049999999998
GRISCELLI SYNDROME TYPE 1	0.0322581	1.6129049999999998
YOU-HOOVER-FONG SYNDROME; YHFS	0.0322581	1.6129049999999998
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.6129049999999998
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03216375	1.6081874999999999
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.03216375	1.6081874999999999
HYPERLYSINEMIA, TYPE I	0.03216375	1.6081874999999999
GRFOMA	0.032105	1.60525
VASCULAR EHLERS-DANLOS SYNDROME	0.03198653	1.5993264999999999
VELO-FACIAL-SKELETAL SYNDROME	0.031816870000000004	1.5908435000000003
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.03179152	1.5895759999999999
KEUTEL SYNDROME; KTLS	0.03174927	1.5874635000000001
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.031684050000000005	1.5842025000000002
KNOBLOCH SYNDROME	0.031649790000000004	1.5824895
QAZI-MARKOUIZOS SYNDROME	0.03164625	1.5823125
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.03163368	1.5816839999999999
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.03151441	1.5757205
EPIDERMAL NEVUS SYNDROME	0.031467840000000004	1.5733920000000001
CK SYNDROME	0.03144074	1.5720370000000001
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.03142225	1.5711125
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.031359490000000004	1.5679745000000003
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.03134923	1.5674614999999998
COFFIN-SIRIS SYNDROME 4; CSS4	0.031244889999999997	1.5622444999999998
COFFIN-SIRIS SYNDROME 3; CSS3	0.031244889999999997	1.5622444999999998
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.03101772	1.550886
2Q23.1 MICRODELETION SYNDROME	0.030829290000000002	1.5414645
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.03073191	1.5365955
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.030689559999999998	1.5344779999999998
CORNELIA DE LANGE SYNDROME 3	0.03068891	1.5344455
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.03037634	1.518817
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.03037634	1.518817
PAPILLON-LEFÈVRE SYNDROME	0.0303571	1.5178550000000002
RETINAL CAPILLARY MALFORMATION	0.03024694	1.512347
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.03019416	1.509708
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.03014216	1.5071080000000001
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.03003714	1.501857
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.03003445	1.5017225
FLOATING-HARBOR SYNDROME	0.03002145	1.5010725
RUBINSTEIN-TAYBI SYNDROME	0.02998154	1.499077
XP22.13P22.2 DUPLICATION SYNDROME	0.02990747	1.4953735
YOUNG-ONSET PARKINSON DISEASE	0.02988723	1.4943615000000001
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.02970597	1.4852985
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.02969356	1.484678
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.02967996	1.483998
RABSON-MENDENHALL SYNDROME	0.02952075	1.4760375
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.4705899999999998
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	1.4705899999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0294118	1.4705899999999998
AL AMYLOIDOSIS	0.0294118	1.4705899999999998
CURRARINO SYNDROME	0.0294118	1.4705899999999998
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.029320970000000002	1.4660485
DUBOWITZ SYNDROME	0.029092390000000003	1.4546195000000002
CARNEY COMPLEX, TYPE 1; CNC1	0.028963379999999997	1.4481689999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.028800820000000005	1.4400410000000003
OROFACIODIGITAL SYNDROME TYPE 4	0.02871733	1.4358665
WILSON-TURNER SYNDROME	0.028660150000000002	1.4330075000000002
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.028571430000000002	1.4285715
SOMATOSTATINOMA	0.028571430000000002	1.4285715
PPOMA	0.028571430000000002	1.4285715
GLUCAGONOMA	0.028571430000000002	1.4285715
2Q31.1 MICRODELETION SYNDROME	0.02854362	1.427181
SANDHOFF DISEASE	0.02853357	1.4266785
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.02853357	1.4266785
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.02833333	1.4166665
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.02831885	1.4159424999999999
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.02826325	1.4131625
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.02798755	1.3993775
48,XXXY SYNDROME	0.02779805	1.3899025
O'SULLIVAN-MCLEOD SYNDROME	0.027777800000000002	1.3888900000000002
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.027777800000000002	1.3888900000000002
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.3888900000000002
DIMPLES, FACIAL	0.027777800000000002	1.3888900000000002
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.3888900000000002
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.3888900000000002
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.3888900000000002
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.3888900000000002
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	1.3888900000000002
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.3888900000000002
MENKES DISEASE	0.027777800000000002	1.3888900000000002
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.3888900000000002
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.3888900000000002
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.3888900000000002
AMYOTROPHIC LATERAL SCLEROSIS	0.027777800000000002	1.3888900000000002
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.3888900000000002
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	1.3888900000000002
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	1.3888900000000002
OROFACIAL CLEFT 3	0.027777800000000002	1.3888900000000002
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.3888900000000002
SPINOCEREBELLAR ATAXIA TYPE 43	0.027777800000000002	1.3888900000000002
THYROID LYMPHOMA	0.027777800000000002	1.3888900000000002
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	1.3888900000000002
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.3888900000000002
NASAL BONES, ABSENCE OF	0.027777800000000002	1.3888900000000002
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.3888900000000002
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.3888900000000002
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.027777800000000002	1.3888900000000002
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.027777800000000002	1.3888900000000002
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.3888900000000002
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.3888900000000002
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.027777800000000002	1.3888900000000002
CLEFT CHIN	0.027777800000000002	1.3888900000000002
OSTEOSARCOMA	0.027777800000000002	1.3888900000000002
INTERSTITIAL CYSTITIS	0.027777800000000002	1.3888900000000002
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	1.3888900000000002
DWARFISM, LEVI TYPE	0.027777800000000002	1.3888900000000002
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	1.3888900000000002
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.3888900000000002
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	1.3888900000000002
ACATALASEMIA	0.027777800000000002	1.3888900000000002
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.027777800000000002	1.3888900000000002
BUERGER DISEASE	0.027777800000000002	1.3888900000000002
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.3888900000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.027777800000000002	1.3888900000000002
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	1.3888900000000002
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.3888900000000002
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.027777800000000002	1.3888900000000002
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.3888900000000002
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.3888900000000002
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.3888900000000002
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.027777800000000002	1.3888900000000002
CORNELIA DE LANGE SYNDROME 1	0.027716960000000002	1.3858480000000002
ZUNICH NEUROECTODERMAL SYNDROME	0.02771326	1.385663
NON-DISTAL MONOSOMY 20Q	0.02751462	1.375731
15Q26 OVERGROWTH SYNDROME	0.02750756	1.375378
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.02742841	1.3714205
CEDNIK SYNDROME	0.02729085	1.3645425
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.02728491	1.3642455
MARFAN SYNDROME	0.02725595	1.3627975
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.02712455	1.3562275000000001
CONGENITAL HYPOTHYROIDISM	0.027105	1.35525
CHARGE SYNDROME	0.02682233	1.3411164999999998
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.02672414	1.336207
SUSAC SYNDROME	0.02665294	1.332647
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.026585159999999997	1.3292579999999998
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.02652437	1.3262185
NEONATAL MARFAN SYNDROME	0.026515129999999998	1.3257564999999998
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02649351	1.3246755000000001
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0263158	1.31579
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0263158	1.31579
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	1.31579
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0263158	1.31579
KUFOR-RAKEB SYNDROME	0.0263158	1.31579
7Q11.23 DUPLICATION SYNDROME	0.0263158	1.31579
DRAVET SYNDROME	0.0263158	1.31579
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0263158	1.31579
INHERITED CREUTZFELDT-JAKOB DISEASE	0.0263158	1.31579
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0263158	1.31579
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.02630173	1.3150865
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.026279510000000002	1.3139755000000002
SPINOCEREBELLAR ATAXIA TYPE 25	0.02624533	1.3122665
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02621118	1.310559
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.02618021	1.3090104999999999
JACOBSEN SYNDROME	0.02608398	1.3041989999999999
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02601329	1.3006645000000001
CHROMOSOME 17Q12 DELETION SYNDROME	0.0259915	1.299575
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.02598718	1.299359
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.02591788	1.295894
ALAGILLE SYNDROME	0.02584083	1.2920414999999998
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.02573404	1.286702
BARATELA-SCOTT SYNDROME	0.02561898	1.280949
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.025610519999999998	1.2805259999999998
HEREDITARY COPROPORPHYRIA	0.025560760000000002	1.278038
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.02556075	1.2780375
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.02556075	1.2780375
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.02556075	1.2780375
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.02556075	1.2780375
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.02547394	1.273697
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02546448	1.2732240000000001
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02543861	1.2719305
COFFIN-SIRIS SYNDROME	0.02521422	1.260711
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.02500932	1.250466
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.02500932	1.250466
CARCINOID SYNDROME	0.025	1.25
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025	1.25
TIGLIC ACIDEMIA	0.025	1.25
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.025	1.25
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	1.25
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	1.25
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025	1.25
ZOLLINGER-ELLISON SYNDROME	0.025	1.25
ANDROGEN INSENSITIVITY SYNDROME	0.025	1.25
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	1.25
HOOFT DISEASE	0.025	1.25
HYPERLIPOPROTEINEMIA, TYPE I	0.025	1.25
ESTROGEN RESISTANCE SYNDROME	0.025	1.25
ANGIOEDEMA, HEREDITARY, TYPE III	0.025	1.25
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	1.25
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	1.25
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	1.25
ASHERMAN SYNDROME	0.025	1.25
MAPLE SYRUP URINE DISEASE; MSUD	0.025	1.25
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.025	1.25
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.025	1.25
RECURRENT ACUTE PANCREATITIS	0.025	1.25
CZECH DYSPLASIA, METATARSAL TYPE	0.025	1.25
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.025	1.25
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	1.25
VIPOMA	0.025	1.25
GALLBLADDER NEUROENDOCRINE TUMOR	0.025	1.25
ADENOCARCINOMA OF OVARY	0.025	1.25
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	1.25
NEUROENDOCRINE TUMOR OF STOMACH	0.025	1.25
MERCURY POISONING	0.025	1.25
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	1.25
ILEAL NEUROENDOCRINE TUMOR	0.025	1.25
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.025	1.25
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	1.25
DUODENAL NEUROENDOCRINE TUMOR	0.025	1.25
ALKAPTONURIA	0.025	1.25
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	1.25
JEJUNAL NEUROENDOCRINE TUMOR	0.025	1.25
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	1.25
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0249722	1.24861
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.02496664	1.248332
POLYARTERITIS NODOSA	0.02496553	1.2482765
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.02467531	1.2337654999999998
DUPLICATION/INVERSION 15Q11	0.02449299	1.2246495
FOUNTAIN SYNDROME	0.02443555	1.2217775
BRITTLE CORNEA SYNDROME	0.024392979999999998	1.219649
2Q32Q33 MICRODELETION SYNDROME	0.02435638	1.217819
2Q37 MICRODELETION SYNDROME	0.0243483	1.217415
VAN BOGAERT-HOZAY SYNDROME	0.024193279999999998	1.2096639999999999
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02413223	1.2066115
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02413223	1.2066115
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.02410393	1.2051965
PRIMROSE SYNDROME; PRIMS	0.02389484	1.194742
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.02380452	1.190226
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.02378937	1.1894685
KLEEFSTRA SYNDROME	0.02378697	1.1893485000000001
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.02377241	1.1886205
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0237347	1.186735
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.02371107	1.1855535000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.02362492	1.181246
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.02340759	1.1703795
CARDIOFACIOCUTANEOUS SYNDROME	0.023389789999999997	1.1694894999999998
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.023386860000000002	1.169343
17Q21.31 MICRODUPLICATION SYNDROME	0.02334082	1.167041
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.02327128	1.1635639999999998
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.02327024	1.163512
COFFIN-SIRIS SYNDROME 2; CSS2	0.02311481	1.1557405
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.023067749999999998	1.1533875
FAMILIAL COLORECTAL CANCER TYPE X	0.022972060000000002	1.148603
LYNCH SYNDROME	0.022972060000000002	1.148603
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02296947	1.1484735
1P36 DELETION SYNDROME	0.022947150000000003	1.1473575000000003
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.022887940000000002	1.144397
248100 MACROSOMIA ADIPOSA CONGENITA	0.02277415	1.1387075
FRAGILE X SYNDROME	0.022723939999999998	1.136197
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02271326	1.1356629999999999
PFAPA SYNDROME	0.022708080000000002	1.135404
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.022664660000000003	1.1332330000000002
NEPHROSIALIDOSIS	0.02255794	1.127897
MEGAEPIPHYSEAL DWARFISM	0.02255794	1.127897
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.02250764	1.1253819999999999
GYRATE ATROPHY OF CHOROID AND RETINA	0.02246914	1.123457
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.02242475	1.1212375
ARTERIAL TORTUOSITY SYNDROME	0.02239151	1.1195755
SILVER-RUSSELL SYNDROME	0.02237455	1.1187275
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.02226572	1.113286
3MC SYNDROME 1	0.02226572	1.113286
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.02224475	1.1122375
HARROD SYNDROME	0.022225309999999998	1.1112655
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.02220854	1.110427
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.02220854	1.110427
LARON SYNDROME	0.02220854	1.110427
GROWTH HORMONE INSENSITIVITY SYNDROME	0.02220854	1.110427
BARDET-BIEDL SYNDROME 1; BBS1	0.02220241	1.1101204999999998
TEMTAMY SYNDROME	0.02216926	1.108463
KASABACH-MERRITT SYNDROME	0.02198933	1.0994665000000001
SCHAAF-YANG SYNDROME; SHFYNG	0.02195497	1.0977485
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.02188152	1.094076
MENTAL RETARDATION, X-LINKED 107; MRX107	0.021862080000000002	1.093104
4Q21 MICRODELETION SYNDROME	0.02183493	1.0917465
MENTAL RETARDATION, X-LINKED 21	0.02179207	1.0896035
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.02178133	1.0890665000000002
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.02176335	1.0881675
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.021751279999999998	1.087564
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02172414	1.086207
ROLANDIC EPILEPSY	0.02172001	1.0860005000000001
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.021715369999999998	1.0857685
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.021675700000000003	1.0837850000000002
49,XXXXY SYNDROME	0.02167482	1.083741
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.02158066	1.0790330000000001
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.02154809	1.0774044999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.02154714	1.077357
SRD5A3-CDG	0.02154714	1.077357
OCULOCEREBRORENAL SYNDROME OF LOWE	0.02151755	1.0758775
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.02140991	1.0704955
MUCOPOLYSACCHARIDOSIS, TYPE II	0.02139067	1.0695335
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.02139067	1.0695335
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.02139067	1.0695335
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.02139067	1.0695335
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02137363	1.0686815
MENTAL RETARDATION, X-LINKED 98; MRX98	0.02136478	1.068239
MYHRE SYNDROME	0.02136424	1.068212
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.02134172	1.067086
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.021329579999999997	1.066479
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	1.06383
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0212766	1.06383
DYSTONIA 28, CHILDHOOD-ONSET	0.0212766	1.06383
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.0212766	1.06383
PEHO SYNDROME	0.0212766	1.06383
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0212766	1.06383
KEPPEN-LUBINSKY SYNDROME	0.0212766	1.06383
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.0212766	1.06383
JOUBERT SYNDROME 30; JBTS30	0.0212766	1.06383
SPINOCEREBELLAR ATAXIA 12	0.0212766	1.06383
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	1.06383
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0212766	1.06383
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.0212766	1.06383
HUNTINGTON DISEASE; HD	0.0212766	1.06383
JOUBERT SYNDROME 23; JBTS23	0.0212766	1.06383
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.0212766	1.06383
KURU, SUSCEPTIBILITY TO	0.0212766	1.06383
X-LINKED RETINOSCHISIS	0.0212766	1.06383
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	1.06383
JUVENILE ABSENCE EPILEPSY	0.0212766	1.06383
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	1.06383
JUVENILE MYOCLONIC EPILEPSY	0.0212766	1.06383
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	1.06383
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.0212766	1.06383
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	1.06383
PRIMARY BASILAR INVAGINATION	0.0212766	1.06383
RAVINE SYNDROME	0.0212766	1.06383
AICARDI-GOUTIERES SYNDROME 7	0.0212766	1.06383
NEUROCUTANEOUS MELANOCYTOSIS	0.02127193	1.0635965
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.02127193	1.0635965
KBG SYNDROME	0.02114655	1.0573275
HISTIDINEMIA	0.021071490000000002	1.0535745
MANITOBA OCULOTRICHOANAL SYNDROME	0.02098912	1.049456
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02098912	1.049456
ENDOCARDIAL FIBROELASTOSIS	0.02093144	1.046572
DERMOIDS OF CORNEA	0.0208333	1.041665
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	1.041665
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	1.041665
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	1.041665
UNIQUE GREEN PHENOMENON	0.0208333	1.041665
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	1.041665
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0208333	1.041665
STICKLER SYNDROME, TYPE III	0.0208333	1.041665
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	1.041665
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	1.041665
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	1.041665
CRANDALL SYNDROME	0.0208333	1.041665
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	1.041665
GAUCHER DISEASE, TYPE I	0.0208333	1.041665
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	1.041665
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	1.041665
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	1.041665
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	1.041665
MYELINATED OPTIC NERVE FIBERS	0.0208333	1.041665
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	1.041665
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	1.041665
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	1.041665
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	1.041665
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	1.041665
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	1.041665
IMINOGLYCINURIA	0.0208333	1.041665
PUPIL, EGG-SHAPED	0.0208333	1.041665
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	1.041665
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	1.041665
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	1.041665
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	1.041665
PREPAPILLARY VASCULAR LOOPS	0.0208333	1.041665
ERYTHERMALGIA, PRIMARY	0.02081283	1.0406415
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02077497	1.0387485
TONNE-KALSCHEUER SYNDROME; TOKAS	0.02075005	1.0375025
CYCLIC VOMITING SYNDROME	0.02064596	1.0322980000000002
9Q33.3Q34.11 MICRODELETION SYNDROME	0.02063094	1.031547
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.02059204	1.029602
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.02057036	1.028518
KOOLEN-DE VRIES SYNDROME; KDVS	0.02045174	1.022587
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.020416249999999997	1.0208125
KLEEFSTRA SYNDROME	0.02038423	1.0192115
RING CHROMOSOME 12 SYNDROME	0.0202947	1.014735
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.02028121	1.0140605
SAETHRE-CHOTZEN SYNDROME	0.02017277	1.0086385
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.02009824	1.004912
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.02009824	1.004912
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.02003952	1.001976
INHERITED EPIDERMOLYSIS BULLOSA	0.02	1.0
RINGED HAIR	0.02	1.0
JUVENILE HYALINE FIBROMATOSIS	0.02	1.0
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	1.0
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	1.0
WERNER SYNDROME; WRN	0.02	1.0
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	1.0
NEVUS COMEDONICUS SYNDROME	0.02	1.0
MIDPHALANGEAL HAIR	0.02	1.0
STRIATE PALMOPLANTAR KERATODERMA	0.02	1.0
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	1.0
FAMILIAL MELANOMA	0.02	1.0
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	1.0
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	1.0
DISSECTING CELLULITIS OF THE SCALP	0.02	1.0
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	1.0
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	1.0
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	1.0
HAIRY NOSE TIP	0.02	1.0
TRICHODENTOOSSEOUS SYNDROME	0.02	1.0
CATATRICHY	0.02	1.0
DARIER DISEASE	0.02	1.0
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	1.0
HAIR WHORL	0.02	1.0
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.01998666	0.999333
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.019948189999999998	0.9974094999999998
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.019905939999999997	0.9952969999999999
WEILL-MARCHESANI SYNDROME 2; WMS2	0.019905939999999997	0.9952969999999999
WEILL-MARCHESANI SYNDROME 1; WMS1	0.019905939999999997	0.9952969999999999
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.019905939999999997	0.9952969999999999
CURRY-JONES SYNDROME	0.01989938	0.9949690000000001
DISTAL MONOSOMY 12Q	0.01986672	0.993336
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.01985932	0.992966
HOLOPROSENCEPHALY	0.01983811	0.9919055
THORACOMELIC DYSPLASIA	0.01983238	0.991619
WEAVER SYNDROME	0.01977277	0.9886385
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.019736709999999998	0.9868354999999999
MARSHALL-SMITH SYNDROME	0.0197003	0.985015
FG SYNDROME TYPE 1	0.01967372	0.983686
RIDDLE SYNDROME	0.01965022	0.982511
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0196181	0.9809049999999999
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01958653	0.9793265000000001
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.01957246	0.978623
PARANA HARD SKIN SYNDROME	0.01954225	0.9771125
ACTH-DEPENDENT CUSHING SYNDROME	0.01954225	0.9771125
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.01954225	0.9771125
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.01954225	0.9771125
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.019536809999999998	0.9768404999999999
TURNER SYNDROME	0.019536809999999998	0.9768404999999999
MONOSOMY X	0.019536809999999998	0.9768404999999999
MOSAIC MONOSOMY X	0.019536809999999998	0.9768404999999999
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.01950913	0.9754565
15Q OVERGROWTH SYNDROME	0.01947769	0.9738844999999999
CONGENITAL STATIONARY NIGHT BLINDNESS	0.019427129999999997	0.9713564999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.01942275	0.9711375
LEGIUS SYNDROME	0.01939872	0.969936
ALAGILLE SYNDROME 1; ALGS1	0.019372849999999997	0.9686424999999999
FEINGOLD SYNDROME 1; FGLDS1	0.01935538	0.9677689999999999
ALAZAMI-YUAN SYNDROME	0.019354370000000003	0.9677185000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.01934549	0.9672745
ODONTOCHONDRODYSPLASIA; ODCD	0.01932233	0.9661164999999999
12Q14 MICRODELETION SYNDROME	0.01931058	0.9655290000000001
CHROMOSOME 1P36 DELETION SYNDROME	0.01928175	0.9640875
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.01917126	0.9585629999999999
WRINKLY SKIN SYNDROME	0.019170919999999998	0.9585459999999999
DE BARSY SYNDROME	0.019170919999999998	0.9585459999999999
HAMAMY SYNDROME; HMMS	0.019170919999999998	0.9585459999999999
TRISOMY X	0.01911639	0.9558195
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01910591	0.9552955
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.01910243	0.9551215
LEIGH SYNDROME; LS	0.01910243	0.9551215
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.01904262	0.952131
GM1 GANGLIOSIDOSIS	0.01900304	0.9501519999999999
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.01895161	0.9475805
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.01891358	0.9456789999999999
MILROY DISEASE	0.01891358	0.9456789999999999
LEPRECHAUNISM	0.018903299999999998	0.9451649999999999
PROLIDASE DEFICIENCY	0.018903299999999998	0.9451649999999999
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01887219	0.9436095
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.943395
TOE, MISSHAPEN	0.0188679	0.943395
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.943395
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.943395
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.943395
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.943395
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.943395
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.943395
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.943395
VESICOURETERAL REFLUX 1	0.0188679	0.943395
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.943395
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.943395
LETTERER-SIWE DISEASE	0.0188679	0.943395
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.943395
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.943395
CARPAL DISPLACEMENT	0.0188679	0.943395
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.943395
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.943395
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.943395
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.943395
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.943395
BAND HETEROTOPIA; BH	0.0188679	0.943395
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.943395
KNUCKLE PADS	0.0188679	0.943395
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.943395
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0188679	0.943395
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.943395
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.943395
TRACHEOBRONCHOMEGALY	0.0188679	0.943395
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.943395
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.943395
PUBIC BONE DYSPLASIA	0.0188679	0.943395
RAYNAUD DISEASE	0.0188679	0.943395
THROMBOCYTOPENIA 3	0.0188679	0.943395
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.943395
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.943395
VAN DEN BOSCH SYNDROME	0.0188679	0.943395
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.943395
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.943395
HHHH SYNDROME	0.0188679	0.943395
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.943395
SPINAL ARACHNOIDITIS	0.0188679	0.943395
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.943395
MONOPHALANGY OF GREAT TOE	0.0188679	0.943395
GAUCHER DISEASE, PERINATAL LETHAL	0.01885546	0.9427730000000001
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01884622	0.942311
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.01884622	0.942311
BARBER-SAY SYNDROME; BBRSAY	0.01884622	0.942311
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.018827430000000003	0.9413715000000001
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.01871894	0.935947
16P11.2P12.2 MICRODELETION SYNDROME	0.01869736	0.934868
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01865822	0.9329109999999999
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.018645039999999998	0.9322519999999999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.01862675	0.9313375
19P13.13 MICRODELETION SYNDROME	0.01858043	0.9290215
RAYNAUD-CLAES SYNDROME; MRXSRC	0.01857596	0.9287979999999999
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.01857585	0.9287925
SNEDDON SYNDROME	0.01857585	0.9287925
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.01857585	0.9287925
FAMILIAL PAROXYSMAL ATAXIA	0.01857585	0.9287925
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.01857585	0.9287925
ABETAL34V AMYLOIDOSIS	0.01857585	0.9287925
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.01853952	0.926976
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.01853952	0.926976
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.01852059	0.9260295
MEGALENCEPHALY	0.0185185	0.925925
SHORT STATURE DUE TO PRIMARY ACID-LABILE SUBUNIT DEFICIENCY	0.0185185	0.925925
PRADER-WILLI SYNDROME (TYPE 1)	0.0185185	0.925925
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0185185	0.925925
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.0185185	0.925925
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0185185	0.925925
PRADER-WILLI SYNDROME (TYPE 2)	0.0185185	0.925925
ALSTROM SYNDROME; ALMS	0.0185185	0.925925
XQ27.3Q28 DUPLICATION SYNDROME	0.0185185	0.925925
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.0185185	0.925925
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0185185	0.925925
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.0184683	0.923415
SOTOS SYNDROME	0.0184462	0.92231
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.018445510000000002	0.9222755000000001
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.01837532	0.918766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.018297579999999997	0.9148789999999999
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01828532	0.914266
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01828532	0.914266
INDOLENT SYSTEMIC MASTOCYTOSIS	0.0182805	0.9140250000000001
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.018278500000000003	0.9139250000000001
TRISOMY 17P	0.01826802	0.913401
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01822878	0.911439
CINCA SYNDROME	0.01820728	0.910364
LATERAL MENINGOCELE SYNDROME	0.0181893	0.909465
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.01818558	0.909279
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	0.018181799999999998	0.90909
CONE-ROD DYSTROPHY 18	0.018181799999999998	0.90909
MYOPIA 3	0.018181799999999998	0.90909
VAN DEN BOSCH SYNDROME	0.018181799999999998	0.90909
STICKLER SYNDROME, TYPE V; STL5	0.018181799999999998	0.90909
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.018181799999999998	0.90909
APLASIA CUTIS-MYOPIA SYNDROME	0.018181799999999998	0.90909
JUVENILE GLAUCOMA	0.018181799999999998	0.90909
WEILL-MARCHESANI SYNDROME	0.018181799999999998	0.90909
KNOBLOCH SYNDROME 1; KNO1	0.018181799999999998	0.90909
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.018181799999999998	0.90909
RETINITIS PIGMENTOSA 51; RP51	0.018181799999999998	0.90909
%613969 MYOPIA 19, AUTOSOMAL DOMINANT; MYP19	0.018181799999999998	0.90909
SINUS NODE DISEASE AND MYOPIA	0.018181799999999998	0.90909
MENTAL RETARDATION, X-LINKED 92	0.018181799999999998	0.90909
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.018181799999999998	0.90909
MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26	0.018181799999999998	0.90909
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.018181799999999998	0.90909
MYOPIA 25, AUTOSOMAL DOMINANT	0.018181799999999998	0.90909
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.018181799999999998	0.90909
DEAFNESS AND MYOPIA; DFNMYP	0.018181799999999998	0.90909
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.018181799999999998	0.90909
MYOPIA 17	0.018181799999999998	0.90909
MYOPIA 5	0.018181799999999998	0.90909
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.018181799999999998	0.90909
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.01803995	0.9019975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.01802911	0.9014555000000001
COFFIN-SIRIS SYNDROME 6; CSS6	0.01798366	0.899183
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.01793662	0.896831
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.01789545	0.8947725
EDINBURGH MALFORMATION SYNDROME	0.01787634	0.8938170000000001
BOHRING-OPITZ SYNDROME	0.017858799999999998	0.8929399999999998
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0178571	0.8928550000000001
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0178571	0.8928550000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0178571	0.8928550000000001
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.0178571	0.8928550000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0178571	0.8928550000000001
ADDUCTED THUMBS SYNDROME	0.0178571	0.8928550000000001
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0178571	0.8928550000000001
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0178571	0.8928550000000001
WARBURG MICRO SYNDROME 3; WARBM3	0.0178571	0.8928550000000001
RAMON SYNDROME	0.0178571	0.8928550000000001
PORPHYRIA CUTANEA TARDA, TYPE I	0.0178571	0.8928550000000001
TENORIO SYNDROME; TNORS	0.0178571	0.8928550000000001
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0178571	0.8928550000000001
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0178571	0.8928550000000001
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	0.0178571	0.8928550000000001
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.017840579999999998	0.892029
SMITH-FINEMAN-MYERS SYNDROME	0.01782607	0.8913035
WHITE-SUTTON SYNDROME; WHSUS	0.01778197	0.8890985
WIEDEMANN-STEINER SYNDROME; WDSTS	0.01776117	0.8880585
MUCOPOLYSACCHARIDOSIS TYPE 1	0.01775771	0.8878855
MUCOLIPIDOSIS TYPE II	0.01775771	0.8878855
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.01772601	0.8863005
DISTAL MONOSOMY 15Q	0.01772601	0.8863005
ZTTK SYNDROME; ZTTKS	0.01771306	0.8856529999999999
KABUKI SYNDROME 1	0.01770874	0.885437
5Q35 MICRODUPLICATION SYNDROME	0.017692680000000002	0.8846340000000001
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.01767819	0.8839095
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.017627590000000002	0.8813795000000001
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0175401	0.8770049999999999
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.01750024	0.875012
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.01749435	0.8747174999999999
MONOSOMY 18Q	0.01746198	0.873099
22Q11.2 MICRODUPLICATION SYNDROME	0.017442600000000003	0.8721300000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.01740283	0.8701415
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.01731396	0.865698
X-LINKED ADRENOLEUKODYSTROPHY	0.01729243	0.8646215
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0172811	0.864055
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.0172789	0.863945
PITT-HOPKINS SYNDROME	0.01727108	0.863554
SOTOS SYNDROME 2	0.01725946	0.862973
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.01725946	0.862973
RENPENNING SYNDROME	0.01725946	0.862973
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.01725946	0.862973
JUMPING FRENCHMAN OF MAINE	0.0172414	0.86207
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.86207
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.86207
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.86207
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.86207
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.86207
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.86207
SICKLE CELL ANEMIA	0.0172414	0.86207
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.86207
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.86207
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.86207
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.86207
CARDIAC ARRHYTHMIA	0.0172414	0.86207
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.86207
DIASTEMATOMYELIA	0.0172414	0.86207
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.86207
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.86207
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.86207
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.86207
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.86207
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.86207
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.86207
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.86207
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.86207
PALMOMENTAL REFLEX	0.0172414	0.86207
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.86207
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.86207
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.86207
MOSAIC TRISOMY 15	0.0172414	0.86207
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.86207
MOTION SICKNESS	0.0172414	0.86207
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.86207
MYOPATHY, CONGENITAL	0.0172414	0.86207
RHEUMATOID ARTHRITIS	0.0172414	0.86207
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.86207
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.86207
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.86207
CERVICAL RIB	0.0172414	0.86207
269800 SENILE PLAQUE FORMATION	0.0172414	0.86207
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.86207
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.86207
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.86207
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.86207
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.86207
TRANSSEXUALITY	0.0172414	0.86207
ALCOHOL DEPENDENCE	0.0172414	0.86207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.01723854	0.861927
SECKEL SYNDROME	0.017200180000000002	0.8600090000000001
LICHTENSTEIN SYNDROME	0.01719646	0.859823
PELIZAEUS-MERZBACHER DISEASE	0.017175290000000003	0.8587645000000002
SUMMITT SYNDROME	0.0171297	0.856485
LUSCAN-LUMISH SYNDROME; LLS	0.01706146	0.853073
ANGELMAN SYNDROME	0.017040100000000002	0.8520050000000001
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.01703999	0.8519995
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01700325	0.8501625
PMM2-CDG	0.01695797	0.8478985
APERT SYNDROME	0.0169478	0.84739
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.0169475	0.847375
19P13.3 MICRODUPLICATION SYNDROME	0.01691365	0.8456824999999999
COFFIN-SIRIS SYNDROME 7; CSS7	0.01691154	0.8455769999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.01685507	0.8427534999999999
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.01673445	0.8367225
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.01672332	0.836166
ZELLWEGER SYNDROME	0.01670645	0.8353225000000001
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.01667896	0.833948
ACHALASIA-MICROCEPHALY SYNDROME	0.01660466	0.830233
SCLEROSTEOSIS 1; SOST1	0.01656418	0.8282090000000001
BARDET-BIEDL SYNDROME	0.01640625	0.8203125
AROMATASE DEFICIENCY	0.01640625	0.8203125
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01640529	0.8202645
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.01633446	0.816723
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.01625553	0.8127765
JABERI-ELAHI SYNDROME; JABELS	0.01621665	0.8108325
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.01615966	0.807983
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.01613898	0.806949
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01611021	0.8055105
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.01609034	0.804517
MULTIPLE EPIPHYSEAL DYSPLASIA	0.01609034	0.804517
HURLER-SCHEIE SYNDROME	0.01603357	0.8016785000000001
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.01603357	0.8016785000000001
KOOLEN-DE VRIES SYNDROME	0.016015210000000002	0.8007605000000001
NANCE-HORAN SYNDROME	0.01601413	0.8007065000000001
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.01601413	0.8007065000000001
ADULT-ONSET NEMALINE MYOPATHY	0.01601413	0.8007065000000001
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.01601413	0.8007065000000001
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.01601413	0.8007065000000001
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.01601413	0.8007065000000001
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.01601413	0.8007065000000001
NEMALINE MYOPATHY 1; NEM1	0.01601413	0.8007065000000001
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.01601413	0.8007065000000001
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.01601413	0.8007065000000001
BRANCHIOOTORENAL SYNDROME 1	0.01601413	0.8007065000000001
KNIEST-LIKE DYSPLASIA, LETHAL	0.015971430000000002	0.7985715000000001
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.01596885	0.7984424999999999
HAREL-YOON SYNDROME; HAYOS	0.01596885	0.7984424999999999
DOWN SYNDROME	0.01592381	0.7961905
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0159014	0.7950699999999999
FLOATING-HARBOR SYNDROME	0.01586892	0.7934460000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.01585565	0.7927825
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.01582844	0.791422
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.01581817	0.7909085
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.01581596	0.790798
CODAS SYNDROME	0.0157596	0.7879799999999999
TETRASOMY 9P	0.01575782	0.7878909999999999
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.01573784	0.7868919999999999
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.01572831	0.7864154999999999
EMANUEL SYNDROME	0.01568926	0.784463
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.01566483	0.7832415
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.01566294	0.783147
6Q16 MICRODELETION SYNDROME	0.01565209	0.7826045
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.01563056	0.7815280000000001
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.015624349999999999	0.7812174999999999
RENAL TUBULAR DYSGENESIS	0.01560366	0.780183
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.01551799	0.7758995000000001
LARSEN SYNDROME	0.01550339	0.7751695000000001
TRISOMY 20P	0.015487879999999999	0.7743939999999999
CHOPS SYNDROME; CHOPS	0.01547119	0.7735595
HALLERMANN-STREIFF SYNDROME; HSS	0.01542661	0.7713305
1Q41Q42 MICRODELETION SYNDROME	0.01527497	0.7637485
RABIES	0.015268400000000001	0.7634200000000001
SPINOCEREBELLAR ATAXIA TYPE 36	0.015268400000000001	0.7634200000000001
NORRIE DISEASE	0.015268400000000001	0.7634200000000001
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.01525927	0.7629635
16Q24.3 MICRODELETION SYNDROME	0.015233109999999998	0.7616554999999999
OCULOECTODERMAL SYNDROME; OES	0.015227680000000002	0.7613840000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.01522354	0.761177
CAFFEY DISEASE	0.015182190000000002	0.7591095000000001
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	0.759013
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.01517233	0.7586165
DESBUQUOIS DYSPLASIA 1	0.01514178	0.757089
RING CHROMOSOME 7 SYNDROME	0.01505353	0.7526765000000001
NANCE-HORAN SYNDROME	0.01504239	0.7521194999999999
SHUKLA-VERNON SYNDROME; SHUVER	0.0150123	0.7506149999999999
MENKES DISEASE	0.014983110000000001	0.7491555000000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.01498231	0.7491155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.01497757	0.7488785
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.014976899999999998	0.7488449999999999
MUCOPOLYSACCHARIDOSIS TYPE 3	0.01496914	0.748457
TETRASOMY X	0.01489724	0.744862
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.01487788	0.7438939999999999
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.01486653	0.7433265
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.01485497	0.7427485
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.01484004	0.742002
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.01482684	0.7413420000000001
11Q22.2Q22.3 MICRODELETION SYNDROME	0.01480934	0.740467
PETERS PLUS SYNDROME	0.014780640000000001	0.739032
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.014751750000000001	0.7375875000000001
1P21.3 MICRODELETION SYNDROME	0.01470872	0.735436
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01466855	0.7334275
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.01463376	0.731688
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.014623589999999999	0.7311795
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.014623589999999999	0.7311795
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014619880000000002	0.7309940000000001
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.01461454	0.730727
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.01461032	0.7305159999999999
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.01461032	0.7305159999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.014603789999999998	0.7301894999999999
AL KAISSI SYNDROME; ALKAS	0.014583110000000002	0.7291555000000001
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01458016	0.729008
HELSMOORTEL-VAN DER AA SYNDROME	0.0145331	0.726655
KBG SYNDROME	0.01452488	0.726244
THANATOPHORIC DYSPLASIA TYPE 2	0.014514270000000001	0.7257135
THANATOPHORIC DYSPLASIA	0.014514270000000001	0.7257135
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.01449554	0.724777
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.014492660000000001	0.7246330000000001
OROFACIODIGITAL SYNDROME TYPE 6	0.014488830000000001	0.7244415000000001
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.01448207	0.7241035
FRAGILE X MENTAL RETARDATION SYNDROME	0.01440665	0.7203325
10Q22.3Q23.3 MICRODELETION SYNDROME	0.014388920000000001	0.719446
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.014345580000000002	0.7172790000000001
PEDIATRIC-ONSET GRAVES DISEASE	0.01425131	0.7125655
WEAVER SYNDROME	0.01424255	0.7121275
MONOSOMY 5P	0.01424255	0.7121275
LANDAU-KLEFFNER SYNDROME	0.014236410000000001	0.7118205000000001
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.014224140000000001	0.711207
FETAL MINOXIDIL SYNDROME	0.014224140000000001	0.711207
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.01419244	0.709622
CRYPTOCOCCOSIS	0.014148270000000001	0.7074135
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.014148270000000001	0.7074135
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014148270000000001	0.7074135
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.014148270000000001	0.7074135
PINEOBLASTOMA	0.014148270000000001	0.7074135
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0141072	0.70536
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.0141072	0.70536
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.014074320000000001	0.703716
PFEIFFER SYNDROME	0.01397833	0.6989165
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.01397833	0.6989165
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.013978029999999999	0.6989015
9P13 MICRODELETION SYNDROME	0.01393906	0.6969529999999999
LEGIONELLOSIS	0.013936150000000001	0.6968075
IMMUNOGLOBULIN A VASCULITIS	0.013936150000000001	0.6968075
VIRAL HEMORRHAGIC FEVER	0.013936150000000001	0.6968075
BEHÇET DISEASE	0.013936150000000001	0.6968075
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.013936150000000001	0.6968075
KAWASAKI DISEASE	0.013936150000000001	0.6968075
MALIGNANT ATROPHIC PAPULOSIS	0.013936150000000001	0.6968075
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.01392351	0.6961755000000001
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.013914840000000001	0.6957420000000001
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.01390453	0.6952265
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.01389143	0.6945715
PALLISTER-KILLIAN SYNDROME	0.013867550000000001	0.6933775000000001
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.013850920000000001	0.692546
COHEN SYNDROME	0.013831900000000001	0.6915950000000001
MICROTRIPLICATION 11Q24.1	0.01380528	0.690264
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0137797	0.6889850000000001
PROGEROID SYNDROME, PETTY TYPE	0.01374533	0.6872665
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.01371017	0.6855085000000001
COFFIN-LOWRY SYNDROME	0.013703340000000001	0.6851670000000001
EMANUEL SYNDROME	0.013696159999999999	0.684808
SHORT SYNDROME	0.01369381	0.6846905000000001
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.01368213	0.6841065000000001
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.013669839999999999	0.683492
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.01365191	0.6825955
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.013651360000000001	0.6825680000000001
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01362693	0.6813465000000001
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.0136212	0.68106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0136135	0.680675
CRANIOFRONTONASAL DYSPLASIA	0.01361056	0.680528
MELNICK-NEEDLES SYNDROME	0.01361056	0.680528
TRANSALDOLASE DEFICIENCY	0.013593990000000002	0.6796995000000001
DISTAL TRISOMY 18Q	0.01353576	0.6767880000000001
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.01350642	0.675321
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.01350642	0.675321
SECKEL SYNDROME 1; SCKL1	0.013503540000000001	0.675177
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.013499710000000002	0.6749855000000001
CONGENITAL MYASTHENIC SYNDROME	0.013499710000000002	0.6749855000000001
PERLMAN SYNDROME	0.01349386	0.674693
BARBER-SAY SYNDROME	0.01348912	0.674456
GORLIN-CHAUDHRY-MOSS SYNDROME	0.01348912	0.674456
SWEENEY-COX SYNDROME; SWCOS	0.01348912	0.674456
HURLER SYNDROME	0.01338779	0.6693895
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.01338779	0.6693895
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.013375350000000001	0.6687675000000001
POTOCKI-LUPSKI SYNDROME	0.01333058	0.666529
13Q12.3 MICRODELETION SYNDROME	0.01332563	0.6662815
MONOSOMY 9Q22.3	0.01330446	0.665223
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.013242780000000001	0.662139
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.013182949999999999	0.6591475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.01310942	0.655471
WAARDENBURG-SHAH SYNDROME	0.013080000000000001	0.654
GITELMAN SYNDROME	0.013080000000000001	0.654
TYPHOID	0.013080000000000001	0.654
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.01303692	0.651846
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.01303692	0.651846
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.01303255	0.6516275
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.01303056	0.651528
MARSHALL SYNDROME	0.013006680000000001	0.6503340000000001
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.012989210000000001	0.6494605
11P15.4 MICRODUPLICATION SYNDROME	0.01297263	0.6486315
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.01294843	0.6474215
17P11.2 MICRODUPLICATION SYNDROME	0.012947110000000001	0.6473555000000001
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.012945120000000001	0.647256
1Q21.1 MICRODELETION SYNDROME	0.01292099	0.6460495
47,XYY SYNDROME	0.01290521	0.6452605
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.012904160000000001	0.6452080000000001
SCLERODERMA	0.012904160000000001	0.6452080000000001
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.01290377	0.6451885
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.01285602	0.642801
ADIPOSIS DOLOROSA	0.01285402	0.6427010000000001
SAY-BARBER-MILLER SYNDROME	0.01280924	0.640462
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.01279013	0.6395065
ELSAHY-WATERS SYNDROME; ESWS	0.01277572	0.6387860000000001
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01273052	0.636526
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.01273052	0.636526
3M SYNDROME	0.012704690000000001	0.6352345
OSTEOGENESIS IMPERFECTA	0.012704690000000001	0.6352345
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.01267818	0.6339090000000001
OCCIPITAL HORN SYNDROME	0.01266279	0.6331395
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.01266279	0.6331395
EAR-PATELLA-SHORT STATURE SYNDROME	0.01266279	0.6331395
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.012652769999999999	0.6326385
FRONTOMETAPHYSEAL DYSPLASIA	0.012652769999999999	0.6326385
MEHMO SYNDROME; MEHMO	0.01264585	0.6322925
STICKLER SYNDROME	0.012638910000000001	0.6319455
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.01263592	0.631796
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.012621440000000001	0.6310720000000001
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.01254361	0.6271805
STICKLER SYNDROME, TYPE II	0.01252661	0.6263305
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.01250776	0.6253879999999999
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.01250776	0.6253879999999999
RUVALCABA SYNDROME	0.0125	0.625
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.0125	0.625
MICRO SYNDROME	0.0125	0.625
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.0125	0.625
CERVICAL HYPERTRICHOSIS-PERIPHERAL NEUROPATHY SYNDROME	0.0125	0.625
INSULIN-RESISTANCE SYNDROME TYPE A	0.0125	0.625
ACQUIRED PARTIAL LIPODYSTROPHY	0.0125	0.625
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.0125	0.625
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0125	0.625
RAMON SYNDROME	0.0125	0.625
DIASTEMATOMYELIA	0.0125	0.625
PORPHYRIA CUTANEA TARDA	0.0125	0.625
LARGE CONGENITAL MELANOCYTIC NEVUS	0.0125	0.625
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0125	0.625
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.0125	0.625
ERYTHROKERATODERMIA VARIABILIS	0.0125	0.625
ACQUIRED GENERALIZED LIPODYSTROPHY	0.0125	0.625
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.01246495	0.6232475000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.012461970000000001	0.6230985
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.012461970000000001	0.6230985
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.01238083	0.6190415
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01238083	0.6190415
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.01234146	0.617073
CONGENITAL ANALBUMINEMIA	0.01230961	0.6154805
TEMPLE SYNDROME	0.01230961	0.6154805
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.01229996	0.614998
FRAXE INTELLECTUAL DISABILITY	0.012299560000000001	0.614978
GAPO SYNDROME; GAPOS	0.01229192	0.614596
NOONAN SYNDROME 7; NS7	0.01229192	0.614596
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.01227306	0.613653
OVARIAN HYPERSTIMULATION SYNDROME	0.012262309999999998	0.6131154999999999
GONADOBLASTOMA	0.012262309999999998	0.6131154999999999
OVARIAN FIBROTHECOMA	0.012262309999999998	0.6131154999999999
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.01223433	0.6117165
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.01222465	0.6112325
COHEN-GIBSON SYNDROME; COGIS	0.01222465	0.6112325
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.012164620000000001	0.6082310000000001
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.012164620000000001	0.6082310000000001
UNILATERAL POLYMICROGYRIA	0.012164620000000001	0.6082310000000001
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.012164620000000001	0.6082310000000001
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.01213013	0.6065065
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.01211841	0.6059205
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.01211841	0.6059205
MENTAL RETARDATION, X-LINKED 101; MRX101	0.01211841	0.6059205
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.012082	0.6041000000000001
DDOST-CDG	0.012046010000000001	0.6023005
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.01203837	0.6019185
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.01203633	0.6018165
POLYCYSTIC OVARY SYNDROME 1	0.01203633	0.6018165
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.01203633	0.6018165
SLC35A2-CDG	0.01202337	0.6011685
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01200713	0.6003565
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.01198865	0.5994325
TETRASOMY 12P	0.0119792	0.59896
BALLER-GEROLD SYNDROME	0.01197812	0.598906
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.01197479	0.5987395000000001
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	0.5987395000000001
MONOSOMY 22	0.01195529	0.5977645
TRISOMY 5P	0.01193762	0.596881
INFANTILE SIALIC ACID STORAGE DISEASE	0.01193693	0.5968465000000001
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.01193693	0.5968465000000001
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.01193284	0.596642
MARDEN-WALKER SYNDROME	0.01191609	0.5958045000000001
NIEMANN-PICK DISEASE TYPE B	0.01191609	0.5958045000000001
EARLY-ONSET SCHIZOPHRENIA	0.01191609	0.5958045000000001
TUBEROUS SCLEROSIS 2; TSC2	0.01191609	0.5958045000000001
SPASTIC PARAPLEGIA TYPE 7	0.01191609	0.5958045000000001
TUBEROUS SCLEROSIS COMPLEX	0.01191609	0.5958045000000001
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.01191609	0.5958045000000001
TUBEROUS SCLEROSIS-1	0.01191609	0.5958045000000001
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.01191609	0.5958045000000001
LOWE OCULOCEREBRORENAL SYNDROME	0.01190476	0.595238
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.01190476	0.595238
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.01186778	0.5933889999999999
MACS SYNDROME	0.0118669	0.593345
LAMB-SHAFFER SYNDROME	0.011848870000000001	0.5924435
ACHONDROPLASIA	0.011841570000000001	0.5920785000000001
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.01182012	0.591006
GASTROCUTANEOUS SYNDROME	0.01180407	0.5902035
FOCAL DERMAL HYPOPLASIA	0.011787820000000001	0.589391
HOLOPROSENCEPHALY 5; HPE5	0.011779640000000001	0.588982
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.011779640000000001	0.588982
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.01173494	0.5867469999999999
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01170151	0.5850755
16P13.11 MICRODUPLICATION SYNDROME	0.011675660000000001	0.583783
15Q11Q13 MICRODUPLICATION SYNDROME	0.011675660000000001	0.583783
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.01166365	0.5831824999999999
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01166365	0.5831824999999999
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.01166365	0.5831824999999999
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01166365	0.5831824999999999
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.01166365	0.5831824999999999
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.01160408	0.5802039999999999
SIMOSA CRANIOFACIAL SYNDROME	0.01160408	0.5802039999999999
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.01160408	0.5802039999999999
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.01151864	0.575932
KEIPERT SYNDROME	0.011485190000000001	0.5742595
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.01147674	0.5738369999999999
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.01144405	0.5722025000000001
GAPO SYNDROME	0.01139358	0.569679
KABUKI SYNDROME	0.01136276	0.568138
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.01136276	0.568138
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.01131243	0.5656215
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.01131027	0.5655135
CROUZON DISEASE	0.01130083	0.5650415
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01130083	0.5650415
MCDONOUGH SYNDROME	0.01130083	0.5650415
FAMILIAL DYSAUTONOMIA	0.01124107	0.5620535
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.01124107	0.5620535
DISTAL MONOSOMY 19P13.3	0.01123631	0.5618155
POLYVALVULAR HEART DISEASE SYNDROME	0.01123631	0.5618155
KNIEST DYSPLASIA	0.01123553	0.5617765
TOWNES-BROCKS SYNDROME	0.01122702	0.561351
MOEBIUS SYNDROME; MBS	0.011187840000000001	0.559392
JOUBERT SYNDROME 2	0.011187840000000001	0.559392
XIA-GIBBS SYNDROME	0.011187840000000001	0.559392
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.01111662	0.5558310000000001
TETRASOMY 5P	0.01110164	0.555082
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.011094870000000001	0.5547435000000001
HARTNUP DISEASE	0.01104925	0.5524625
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.01104659	0.5523295
TRISOMY 4P	0.01100084	0.550042
MONOSOMY 22Q13.3	0.01099953	0.5499765
SCARF SYNDROME	0.010990080000000001	0.5495040000000001
ACRO-RENAL-MANDIBULAR SYNDROME	0.010989	0.54945
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.010989	0.54945
CRANIOACROFACIAL SYNDROME	0.010989	0.54945
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.010989	0.54945
SHELDON-HALL SYNDROME	0.010989	0.54945
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.010989	0.54945
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.010989	0.54945
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.010989	0.54945
TYPICAL NEMALINE MYOPATHY	0.010989	0.54945
WERNER SYNDROME	0.010989	0.54945
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.010989	0.54945
XFE PROGEROID SYNDROME; XFEPS	0.010989	0.54945
BANGSTAD SYNDROME	0.010989	0.54945
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.010989	0.54945
BLOOM SYNDROME	0.010989	0.54945
OCULOFACIOCARDIODENTAL SYNDROME	0.010989	0.54945
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.010989	0.54945
ALLAN-HERNDON-DUDLEY SYNDROME	0.010989	0.54945
ATYPICAL WERNER SYNDROME	0.010989	0.54945
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0109743	0.548715
MEHMO SYNDROME	0.0109485	0.547425
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.0109485	0.547425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01094372	0.5471860000000001
HYPEREKPLEXIA 2; HKPX2	0.01094372	0.5471860000000001
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.01094372	0.5471860000000001
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.01094372	0.5471860000000001
SHPRINTZEN-GOLDBERG SYNDROME	0.01091477	0.5457385
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.01091477	0.5457385
WHITE FORELOCK WITH MALFORMATIONS	0.010914769999999999	0.5457384999999999
GLASS SYNDROME	0.01087308	0.543654
MENTAL RETARDATION, X-LINKED 72	0.01087308	0.543654
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.01087308	0.543654
SOTOS SYNDROME 3	0.01087308	0.543654
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0108725	0.543625
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01084334	0.542167
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.010840820000000001	0.542041
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.010840820000000001	0.542041
PITT-HOPKINS SYNDROME	0.01081947	0.5409735
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.010814950000000002	0.5407475
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.01081495	0.5407475
BRITTLE CORNEA SYNDROME 2; BCS2	0.01080247	0.5401235
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.01080247	0.5401235
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.01080247	0.5401235
MATERNAL PHENYLKETONURIA	0.01078332	0.539166
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.010783319999999999	0.5391659999999999
DIAMOND-BLACKFAN ANEMIA 1	0.01063781	0.5318904999999999
HENNEKAM-BEEMER SYNDROME	0.01062574	0.531287
8P23.1 MICRODELETION SYNDROME	0.01061606	0.530803
PHELAN-MCDERMID SYNDROME	0.010567779999999999	0.528389
3MC SYNDROME 2	0.010567779999999999	0.528389
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.010567779999999999	0.528389
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.01053754	0.526877
JUVENILE POLYPOSIS OF INFANCY	0.01053553	0.5267765
JUVENILE POLYPOSIS SYNDROME	0.01053553	0.5267765
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.01048961	0.5244805
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0104102	0.52051
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.01040147	0.5200735
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.01040147	0.5200735
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.010364529999999999	0.5182264999999999
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.010364529999999999	0.5182264999999999
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.010316510000000001	0.5158255
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.01031171	0.5155855
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.01028124	0.514062
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.010198720000000001	0.5099360000000001
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.010198720000000001	0.5099360000000001
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.010198720000000001	0.5099360000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010198720000000001	0.5099360000000001
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.010168070000000001	0.5084035
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.010166080000000001	0.5083040000000001
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.01014165	0.5070825
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.01014165	0.5070825
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.01014165	0.5070825
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.01014165	0.5070825
SHPRINTZEN OMPHALOCELE SYNDROME	0.01014165	0.5070825
ATELOSTEOGENESIS, TYPE I; AO1	0.010127500000000001	0.506375
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.010127500000000001	0.506375
GMS SYNDROME	0.010127500000000001	0.506375
MUCOPOLYSACCHARIDOSIS TYPE 7	0.01011252	0.505626
BOHRING-OPITZ SYNDROME	0.01007993	0.5039965000000001
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.01007447	0.5037235
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0100555	0.502775
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.01003721	0.5018604999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.01003721	0.5018604999999999
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.01002708	0.5013540000000001
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.01002708	0.5013540000000001
ANGELMAN SYNDROME	0.01001726	0.5008630000000001
MENTAL RETARDATION, X-LINKED 90	0.01001726	0.5008630000000001
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	0.5008630000000001
MUCOLIPIDOSIS III ALPHA/BETA	0.00998518	0.499259
RENAL COLOBOMA SYNDROME	0.009925650000000001	0.49628250000000007
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00990122	0.49506100000000003
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00989903	0.4949515
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.009868519999999999	0.4934259999999999
HURLER-SCHEIE SYNDROME	0.00985422	0.492711
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.009841889999999999	0.49209449999999993
6Q TERMINAL DELETION SYNDROME	0.00983074	0.49153699999999995
TEMPLE-BARAITSER SYNDROME	0.00981826	0.49091300000000004
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.490196
ARACHNOIDITIS	0.00980392	0.490196
EPISODIC ATAXIA, TYPE 2	0.00980392	0.490196
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.490196
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.490196
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.490196
EPISODIC ATAXIA TYPE 6	0.00980392	0.490196
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.490196
BERNARD-SOULIER SYNDROME	0.00980392	0.490196
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.490196
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00980392	0.490196
PHACE ASSOCIATION	0.00980392	0.490196
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.490196
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00980392	0.490196
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.490196
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.490196
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.490196
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.490196
CITRULLINEMIA TYPE I	0.00980392	0.490196
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.490196
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00980392	0.490196
BENIGN FAMILIAL INFANTILE EPILEPSY	0.00980392	0.490196
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00980392	0.490196
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	0.490196
EPISODIC ATAXIA TYPE 7	0.00980392	0.490196
ATYPICAL TERATOID RHABDOID TUMOR	0.00980392	0.490196
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00980392	0.490196
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00980392	0.490196
SYSTEMIC SCLEROSIS	0.00980392	0.490196
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.490196
VON HIPPEL-LINDAU DISEASE	0.00980392	0.490196
TAKAYASU ARTERITIS	0.00980392	0.490196
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.490196
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.490196
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.490196
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.490196
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.490196
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.490196
EPISODIC ATAXIA, TYPE 6	0.00980392	0.490196
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.00980392	0.490196
KERION CELSI	0.00980392	0.490196
CADASIL	0.00980392	0.490196
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.490196
DEAFNESS-HYPOGONADISM SYNDROME	0.00976105	0.4880525
20Q11.2 MICRODELETION SYNDROME	0.00976105	0.4880525
FIBROCHONDROGENESIS	0.00975551	0.48777550000000003
DISTAL MONOSOMY 1Q	0.00975551	0.48777550000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00975551	0.48777550000000003
SHORT RIB-POLYDACTYLY SYNDROME	0.00975551	0.48777550000000003
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.009754200000000001	0.48771000000000003
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00974475	0.4872375
GAUCHER DISEASE, TYPE II	0.00971991	0.4859955
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00966944	0.48347199999999996
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00965776	0.482888
ADAMS-OLIVER SYNDROME	0.00964869	0.4824345
MICROFORM HOLOPROSENCEPHALY	0.00964869	0.4824345
CHOREOACANTHOCYTOSIS	0.00959671	0.47983549999999997
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00957866	0.47893299999999994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00957866	0.47893299999999994
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00957866	0.47893299999999994
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00957866	0.47893299999999994
OPTIC ATROPHY 11; OPA11	0.00956242	0.478121
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00953799	0.4768995
MENTAL RETARDATION, X-LINKED 102	0.00953799	0.4768995
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00953799	0.4768995
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00953799	0.4768995
PERINEURAL CYST	0.009508570000000001	0.47542850000000003
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.009508570000000001	0.47542850000000003
ACQUIRED METHEMOGLOBINEMIA	0.009508570000000001	0.47542850000000003
MARBURG HEMORRHAGIC FEVER	0.009508570000000001	0.47542850000000003
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.009508570000000001	0.47542850000000003
GRANULOMATOSIS WITH POLYANGIITIS	0.009508570000000001	0.47542850000000003
CUTANEOUS MASTOCYTOSIS	0.009508570000000001	0.47542850000000003
FAMILIAL COLD URTICARIA	0.009508570000000001	0.47542850000000003
EBOLA HEMORRHAGIC FEVER	0.009508570000000001	0.47542850000000003
AMERICAN TRYPANOSOMIASIS	0.009508570000000001	0.47542850000000003
AUTOIMMUNE HEMOLYTIC ANEMIA	0.009508570000000001	0.47542850000000003
LEPTOSPIROSIS	0.009508570000000001	0.47542850000000003
HYPER-IGD SYNDROME	0.009508570000000001	0.47542850000000003
GIANT CELL ARTERITIS	0.009508570000000001	0.47542850000000003
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.009508570000000001	0.47542850000000003
CUTANEOUS MASTOCYTOMA	0.009508570000000001	0.47542850000000003
POLYCYTHEMIA VERA	0.009508570000000001	0.47542850000000003
PREECLAMPSIA	0.009508570000000001	0.47542850000000003
SYSTEMIC MASTOCYTOSIS	0.009508570000000001	0.47542850000000003
PLAGUE	0.009508570000000001	0.47542850000000003
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.009508570000000001	0.47542850000000003
LASSA FEVER	0.009508570000000001	0.47542850000000003
DENGUE FEVER	0.009508570000000001	0.47542850000000003
PRIMARY FAMILIAL POLYCYTHEMIA	0.009508570000000001	0.47542850000000003
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.009508570000000001	0.47542850000000003
RELAPSING FEVER	0.009508570000000001	0.47542850000000003
CARNEY TRIAD	0.009508570000000001	0.47542850000000003
SCRUB TYPHUS	0.009508570000000001	0.47542850000000003
RHABDOID TUMOR	0.009508570000000001	0.47542850000000003
YELLOW FEVER	0.009508570000000001	0.47542850000000003
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.0094637	0.473185
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0094637	0.473185
OROFACIODIGITAL SYNDROME VI	0.0094637	0.473185
PACHYGYRIA, FRONTOTEMPORAL	0.0094637	0.473185
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0094637	0.473185
XP21 MICRODELETION SYNDROME	0.0094637	0.473185
YUNIS-VARON SYNDROME	0.00939248	0.469624
INTERMEDIATE NEMALINE MYOPATHY	0.00939248	0.469624
DISTAL MONOSOMY 17Q	0.00939248	0.469624
GALLOWAY-MOWAT SYNDROME	0.00939248	0.469624
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00939248	0.469624
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00939248	0.469624
RESTRICTIVE DERMOPATHY, LETHAL	0.00939248	0.469624
ROBERTS SYNDROME	0.00939248	0.469624
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00939248	0.469624
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.00938152	0.46907600000000005
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.009375409999999999	0.4687704999999999
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.009375409999999999	0.4687704999999999
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.009375409999999999	0.4687704999999999
IMMUNODEFICIENCY 61; IMD61	0.00937073	0.4685365
OBESITY DUE TO SIM1 DEFICIENCY	0.00937073	0.4685365
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00933945	0.46697249999999996
MONOSOMY 9P	0.009334930000000002	0.46674650000000006
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00932245	0.4661225
MEESTER-LOEYS SYNDROME; MRLS	0.00932245	0.4661225
LATERAL MENINGOCELE SYNDROME	0.00932245	0.4661225
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00929221	0.46461050000000004
CAMPOMELIC DYSPLASIA	0.00929221	0.46461050000000004
HENNEKAM SYNDROME	0.00929221	0.46461050000000004
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00929221	0.46461050000000004
ICF SYNDROME	0.00929221	0.46461050000000004
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00929221	0.46461050000000004
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00929221	0.46461050000000004
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00929221	0.46461050000000004
CRANIOPHARYNGIOMA	0.00928259	0.46412950000000003
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00928259	0.46412950000000003
SECONDARY POLYCYTHEMIA	0.00928259	0.46412950000000003
MENINGIOMA	0.00928259	0.46412950000000003
HYPERTELORISM, TEEBI TYPE	0.009276699999999999	0.46383499999999994
THAUVIN-ROBINET-FAIVRE SYNDROME	0.009276699999999999	0.46383499999999994
8Q21.11 MICRODELETION SYNDROME	0.009276699999999999	0.46383499999999994
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.009206770000000001	0.46033850000000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.009206770000000001	0.46033850000000004
XQ12-Q13.3 DUPLICATION SYNDROME	0.009206770000000001	0.46033850000000004
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00920677	0.4603385
ODONTOCHONDRODYSPLASIA	0.00918065	0.4590325
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00916487	0.4582435
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00916487	0.4582435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.00915452	0.45772599999999997
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0091192	0.45596
FGFR2-RELATED BENT BONE DYSPLASIA	0.0091192	0.45596
BENT BONE DYSPLASIA SYNDROME; BBDS	0.0091192	0.45596
IMMUNODEFICIENCY 49; IMD49	0.0091192	0.45596
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0091192	0.45596
EPILEPSY-TELANGIECTASIA	0.00906638	0.453319
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00906638	0.453319
WAARDENBURG SYNDROME	0.00906638	0.453319
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00906638	0.453319
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00904809	0.4524045
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00904809	0.4524045
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00904809	0.4524045
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00899805	0.44990250000000004
SHORT SYNDROME	0.008962649999999999	0.44813249999999993
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.008962649999999999	0.44813249999999993
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.008962649999999999	0.44813249999999993
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00894899	0.4474495
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00894777	0.4473885
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00894777	0.4473885
DIASTROPHIC DWARFISM	0.00892444	0.446222
NON-DISTAL TRISOMY 10Q	0.00892444	0.446222
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00892444	0.446222
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00892075	0.4460375
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00892075	0.4460375
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00892075	0.4460375
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.008879399999999999	0.44397
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.008817420000000001	0.44087100000000007
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.008813399999999999	0.44066999999999995
ROBINOW-SORAUF SYNDROME	0.008813399999999999	0.44066999999999995
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.43859650000000006
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.43859650000000006
HEREDITARY FOLATE MALABSORPTION	0.00877193	0.43859650000000006
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.43859650000000006
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.43859650000000006
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.43859650000000006
2Q33.1 DELETION SYNDROME	0.00877193	0.43859650000000006
INFANTILE REFSUM DISEASE	0.00877193	0.43859650000000006
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.43859650000000006
BREATH-HOLDING SPELLS	0.00877193	0.43859650000000006
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.43859650000000006
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00877193	0.43859650000000006
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.43859650000000006
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.43859650000000006
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.43859650000000006
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.43859650000000006
ARGININEMIA	0.00877193	0.43859650000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.43859650000000006
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.43859650000000006
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.43859650000000006
MONOSOMY 18P	0.00877193	0.43859650000000006
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.43859650000000006
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.43859650000000006
HISTIDINEMIA	0.00877193	0.43859650000000006
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.43859650000000006
CORTICOBASAL SYNDROME	0.00877193	0.43859650000000006
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00877193	0.43859650000000006
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.43859650000000006
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00877193	0.43859650000000006
LOCKED-IN SYNDROME	0.00877193	0.43859650000000006
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.43859650000000006
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.43859650000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.43859650000000006
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.43859650000000006
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.43859650000000006
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.43859650000000006
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.43859650000000006
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.43859650000000006
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.43859650000000006
JUNG SYNDROME	0.00876639	0.43831950000000003
SONODA SYNDROME	0.00876639	0.43831950000000003
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00876639	0.43831950000000003
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00876639	0.43831950000000003
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00876639	0.43831950000000003
TIMOTHY SYNDROME; TS	0.00876639	0.43831950000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0087396	0.43698000000000004
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00872301	0.4361505
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00868032	0.434016
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00868032	0.434016
STICKLER SYNDROME TYPE 1	0.00868032	0.434016
CRANIOECTODERMAL DYSPLASIA	0.00868032	0.434016
PSEUDOXANTHOMA ELASTICUM	0.00868032	0.434016
FANCONI ANEMIA	0.00864471	0.4322355
CRANIOFACIAL DYSSYNOSTOSIS	0.00864471	0.4322355
DUANE-RADIAL RAY SYNDROME; DRRS	0.00864471	0.4322355
AU-KLINE SYNDROME; AUKS	0.00859656	0.429828
MONOSOMY 13Q34	0.00858541	0.4292705
DISTAL TRISOMY 17Q	0.008561210000000001	0.42806050000000007
PETTIGREW SYNDROME	0.0085587	0.427935
FRIED SYNDROME	0.0085587	0.427935
TEMTAMY SYNDROME; TEMTYS	0.00848339	0.42416950000000003
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00847458	0.423729
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.423729
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00847458	0.423729
DUANE RETRACTION SYNDROME 1	0.00847458	0.423729
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.423729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.00847458	0.423729
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.423729
ADAMS-OLIVER SYNDROME 1; AOS1	0.00847458	0.423729
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.423729
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00847458	0.423729
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00847458	0.423729
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00847458	0.423729
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00847458	0.423729
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00847458	0.423729
HEREDITARY METHEMOGLOBINEMIA	0.00847458	0.423729
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00847458	0.423729
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	0.423729
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00847458	0.423729
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00847458	0.423729
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00847458	0.423729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.00847458	0.423729
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.00847458	0.423729
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00847458	0.423729
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00847458	0.423729
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.423729
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.00847458	0.423729
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00847458	0.423729
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.423729
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00847458	0.423729
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00847458	0.423729
CHROMOSOME 5Q12 DELETION SYNDROME	0.00847458	0.423729
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.00847458	0.423729
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.00847458	0.423729
ROTHMUND-THOMSON SYNDROME	0.008445629999999999	0.4222815
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.008433949999999999	0.42169749999999995
ATKIN-FLAITZ SYNDROME	0.00842894	0.42144699999999996
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00842894	0.42144699999999996
ATKIN-FLAITZ SYNDROME	0.00842894	0.42144699999999996
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.42016800000000004
EBSTEIN MALFORMATION	0.00840336	0.42016800000000004
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.42016800000000004
NEMALINE MYOPATHY 10	0.00840336	0.42016800000000004
ROIFMAN SYNDROME; RFMN	0.00840336	0.42016800000000004
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.42016800000000004
RETINOPATHY OF PREMATURITY	0.00840336	0.42016800000000004
TYSHCHENKO SYNDROME	0.00840336	0.42016800000000004
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.42016800000000004
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.42016800000000004
SCHISIS ASSOCIATION	0.00840336	0.42016800000000004
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.42016800000000004
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.42016800000000004
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.42016800000000004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.42016800000000004
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.42016800000000004
HYDROLETHALUS	0.00840336	0.42016800000000004
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.42016800000000004
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.42016800000000004
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.42016800000000004
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.42016800000000004
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.42016800000000004
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.42016800000000004
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.42016800000000004
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.42016800000000004
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.42016800000000004
OMPHALOCELE	0.00840336	0.42016800000000004
HEC SYNDROME	0.00840336	0.42016800000000004
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.42016800000000004
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.42016800000000004
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00840336	0.42016800000000004
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.42016800000000004
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.42016800000000004
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.42016800000000004
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.42016800000000004
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.42016800000000004
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.42016800000000004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.42016800000000004
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.42016800000000004
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.42016800000000004
FATCO SYNDROME	0.00840336	0.42016800000000004
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.42016800000000004
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.42016800000000004
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.42016800000000004
VACTERL/VATER ASSOCIATION	0.00840336	0.42016800000000004
PEMPHIGOID GESTATIONIS	0.00840336	0.42016800000000004
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.42016800000000004
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00840336	0.42016800000000004
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.42016800000000004
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.42016800000000004
CONGENITAL TOXOPLASMOSIS	0.00840336	0.42016800000000004
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00835033	0.41751649999999996
FETAL TRIMETHADIONE SYNDROME	0.00834581	0.4172905
GERMAN SYNDROME	0.00834581	0.4172905
MEIER-GORLIN SYNDROME 2; MGORS2	0.00833333	0.4166665
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00833333	0.4166665
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00833333	0.4166665
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00833333	0.4166665
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00833333	0.4166665
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00833333	0.4166665
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00833333	0.4166665
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.00833333	0.4166665
CRANIOECTODERMAL DYSPLASIA 4	0.00833333	0.4166665
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00833333	0.4166665
WILSON DISEASE	0.00833333	0.4166665
OCULO-PALATO-CEREBRAL SYNDROME	0.00833333	0.4166665
GIANT AXONAL NEUROPATHY	0.00833333	0.4166665
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00833333	0.4166665
BAZEX SYNDROME; BZX	0.00833333	0.4166665
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.00833333	0.4166665
NEMALINE MYOPATHY 7; NEM7	0.00833333	0.4166665
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00833333	0.4166665
PERIVENTRICULAR NODULAR HETEROTOPIA	0.00833333	0.4166665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00833333	0.4166665
VESICOURETERAL REFLUX 8; VUR8	0.00833333	0.4166665
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00833333	0.4166665
OMODYSPLASIA 1; OMOD1	0.00830309	0.41515450000000004
MAXILLONASAL DYSPLASIA	0.00830309	0.41515450000000004
FIBROCHONDROGENESIS 1; FBCG1	0.00830309	0.41515450000000004
THANATOPHORIC DYSPLASIA TYPE 1	0.00830309	0.41515450000000004
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00830309	0.41515450000000004
EMERY-NELSON SYNDROME	0.00830309	0.41515450000000004
KYPHOMELIC DYSPLASIA	0.00830309	0.41515450000000004
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00830309	0.41515450000000004
OROFACIODIGITAL SYNDROME TYPE 10	0.00830309	0.41515450000000004
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00827502	0.413751
DOORS SYNDROME	0.00823716	0.411858
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.00821765	0.4108825
POPOV-CHANG SYNDROME; POPCHAS	0.00821765	0.4108825
THREE M SYNDROME 2; 3M2	0.00821765	0.4108825
16P13.11 MICRODELETION SYNDROME	0.00817575	0.4087875
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0081344	0.40671999999999997
OTOFACIOCERVICAL SYNDROME	0.0081344	0.40671999999999997
CRANIORHINY	0.00813008	0.406504
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.00813008	0.406504
JOUBERT SYNDROME 10	0.00813008	0.406504
OVARIAN DYSGENESIS 2; ODG2	0.00813008	0.406504
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00813008	0.406504
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00813008	0.406504
46,XY SEX REVERSAL 6; SRXY6	0.00813008	0.406504
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00813008	0.406504
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00813008	0.406504
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.00813008	0.406504
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00813008	0.406504
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00813008	0.406504
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00813008	0.406504
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00813008	0.406504
ACANTHOSIS NIGRICANS-INSULIN RESISTANCE-MUSCLE CRAMPS-ACRAL ENLARGEMENT SYNDROME	0.00813008	0.406504
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00813008	0.406504
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00813008	0.406504
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.00813008	0.406504
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00813008	0.406504
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.0080896	0.40448
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0080896	0.40448
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0080824	0.40412
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0080824	0.40412
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0080824	0.40412
PERIPARTUM CARDIOMYOPATHY	0.00803848	0.40192400000000006
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00803137	0.4015685
CHROMOSOME 18P DELETION SYNDROME	0.00803137	0.4015685
COACH SYNDROME	0.00803137	0.4015685
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00803137	0.4015685
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.007935320000000001	0.39676600000000006
SPONASTRIME DYSPLASIA	0.007935320000000001	0.39676600000000006
DESBUQUOIS SYNDROME	0.007935320000000001	0.39676600000000006
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.007935320000000001	0.39676600000000006
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.007933619999999999	0.39668099999999995
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.007933619999999999	0.39668099999999995
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.007883320000000001	0.39416600000000007
HERMANSKY-PUDLAK SYNDROME	0.0078467	0.392335
CRANIOSYNOSTOSIS 2	0.00784548	0.392274
ALPORT SYNDROME	0.00784548	0.392274
SLC39A8-CDG	0.00782428	0.39121399999999995
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00782428	0.39121399999999995
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00773884	0.386942
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00773884	0.386942
JUVENILE DERMATOMYOSITIS	0.007703659999999999	0.38518299999999994
ACUTE ADRENAL INSUFFICIENCY	0.007703659999999999	0.38518299999999994
PORPHYRIA VARIEGATA	0.007703659999999999	0.38518299999999994
NEUROENDOCRINE TUMOR OF THE RECTUM	0.007703659999999999	0.38518299999999994
NK-CELL ENTEROPATHY	0.007703659999999999	0.38518299999999994
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.007703659999999999	0.38518299999999994
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.007703659999999999	0.38518299999999994
PSEUDOMYXOMA PERITONEI	0.007703659999999999	0.38518299999999994
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.007703659999999999	0.38518299999999994
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.007703659999999999	0.38518299999999994
POLYMYOSITIS	0.007703659999999999	0.38518299999999994
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.007703659999999999	0.38518299999999994
FOODBORNE BOTULISM	0.007703659999999999	0.38518299999999994
VISCERAL MYOPATHY; VSCM	0.007703659999999999	0.38518299999999994
ADDISON DISEASE	0.007703659999999999	0.38518299999999994
BOTULISM	0.007703659999999999	0.38518299999999994
PRIMARY PERITONEAL CARCINOMA	0.007703659999999999	0.38518299999999994
PERITONEAL CYSTIC MESOTHELIOMA	0.007703659999999999	0.38518299999999994
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.007703659999999999	0.38518299999999994
GITELMAN SYNDROME	0.007703659999999999	0.38518299999999994
INFANT BOTULISM	0.007703659999999999	0.38518299999999994
HEREDITARY FRUCTOSE INTOLERANCE	0.007703659999999999	0.38518299999999994
FAMILIAL MEDITERRANEAN FEVER	0.007703659999999999	0.38518299999999994
MALT LYMPHOMA	0.007703659999999999	0.38518299999999994
HIRSCHSPRUNG DISEASE	0.007703659999999999	0.38518299999999994
PORPHYRIA	0.007703659999999999	0.38518299999999994
ACUTE INTERMITTENT PORPHYRIA	0.007703659999999999	0.38518299999999994
CAP POLYPOSIS	0.007703659999999999	0.38518299999999994
PORPHYRIA VARIEGATA	0.007703659999999999	0.38518299999999994
1Q21.1 MICRODUPLICATION SYNDROME	0.00769893	0.38494649999999997
SMITH-LEMLI-OPITZ SYNDROME	0.00769893	0.38494649999999997
MUENKE SYNDROME	0.00769893	0.38494649999999997
BRANCHIOGENIC DEAFNESS SYNDROME	0.00769694	0.384847
MARINESCO-SJÖGREN SYNDROME	0.00769694	0.384847
MIETENS SYNDROME	0.00769694	0.384847
FABRY DISEASE	0.0076658	0.38329
FOCAL DERMAL HYPOPLASIA; FDH	0.00765559	0.3827795
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00765559	0.3827795
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00765559	0.3827795
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00765559	0.3827795
CONGENITAL HYDROCEPHALUS	0.00765559	0.3827795
ISOLATED PLAGIOCEPHALY	0.00765559	0.3827795
SPINOCEREBELLAR ATAXIA TYPE 34	0.00765559	0.3827795
DUANE RETRACTION SYNDROME	0.00765559	0.3827795
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00765559	0.3827795
OTOMANDIBULAR SYNDROME	0.00765559	0.3827795
BENCZE SYNDROME	0.00765559	0.3827795
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.007648629999999999	0.3824315
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.007648629999999999	0.3824315
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00762072	0.381036
1Q44 MICRODELETION SYNDROME	0.007610790000000001	0.38053950000000003
MCDONOUGH SYNDROME	0.007610790000000001	0.38053950000000003
CEREBROFACIOTHORACIC DYSPLASIA	0.007610790000000001	0.38053950000000003
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.007610790000000001	0.38053950000000003
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00759629	0.3798145
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00759629	0.3798145
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00756807	0.3784035
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00756807	0.3784035
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00756807	0.3784035
TRISOMY 12P	0.00756807	0.3784035
OROFACIODIGITAL SYNDROME XV; OFD15	0.00756807	0.3784035
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00756807	0.3784035
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00756807	0.3784035
DYSOSTOSIS, STANESCU TYPE	0.00756807	0.3784035
LARSEN-LIKE SYNDROME	0.00756807	0.3784035
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00756807	0.3784035
DISTAL TRISOMY 5Q	0.00756807	0.3784035
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00756807	0.3784035
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00756807	0.3784035
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00756807	0.3784035
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00756807	0.3784035
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00756807	0.3784035
TRISOMY 8P	0.00753002	0.37650100000000003
20Q13.33 MICRODELETION SYNDROME	0.0074826300000000005	0.3741315
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0074826300000000005	0.3741315
COLE-CARPENTER SYNDROME 2; CLCRP2	0.0074826300000000005	0.3741315
CREE MENTAL RETARDATION SYNDROME	0.0074826300000000005	0.3741315
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0074826300000000005	0.3741315
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0074826300000000005	0.3741315
DISTAL MONOSOMY 3P	0.0074826300000000005	0.3741315
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0074826300000000005	0.3741315
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0074826300000000005	0.3741315
THYROTOXIC PERIODIC PARALYSIS	0.0074776800000000004	0.373884
ADIPOSIS DOLOROSA	0.0074776800000000004	0.373884
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00745651	0.37282550000000003
MULTIMINICORE MYOPATHY	0.00745651	0.37282550000000003
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00745651	0.37282550000000003
COOPER-JABS SYNDROME	0.00745651	0.37282550000000003
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00744073	0.3720365
NEUROFIBROMATOSIS, TYPE I	0.00744073	0.3720365
TRISOMY 8Q	0.00744073	0.3720365
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00744073	0.3720365
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00744073	0.3720365
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.00744073	0.3720365
CLARK-BARAITSER SYNDROME	0.00743982	0.37199099999999996
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00743982	0.37199099999999996
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00743982	0.37199099999999996
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00743982	0.37199099999999996
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00743982	0.37199099999999996
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0074045099999999996	0.3702255
PSEUDOAMINOPTERIN SYNDROME	0.0073993800000000005	0.36996900000000005
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0073993800000000005	0.36996900000000005
SCLEROSTEOSIS 2; SOST2	0.0073993800000000005	0.36996900000000005
CRANIOFRONTONASAL SYNDROME; CFNS	0.0073993800000000005	0.36996900000000005
OROFACIODIGITAL SYNDROME I; OFD1	0.0073993800000000005	0.36996900000000005
OROFACIODIGITAL SYNDROME TYPE 1	0.0073993800000000005	0.36996900000000005
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0073993800000000005	0.36996900000000005
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0073993800000000005	0.36996900000000005
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0073993800000000005	0.36996900000000005
OCULOAURICULOFRONTONASAL SYNDROME	0.0073993800000000005	0.36996900000000005
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.0073645099999999995	0.3682255
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00726147	0.3630735
UROFACIAL SYNDROME	0.00726147	0.3630735
MOSAIC TRISOMY 8	0.00725958	0.362979
CATEL-MANZKE SYNDROME	0.0072003	0.360015
LOEYS-DIETZ SYNDROME	0.0072003	0.360015
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.0072003	0.360015
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0072003	0.360015
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0072003	0.360015
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0072003	0.360015
AUTOSOMAL DOMINANT CUTIS LAXA	0.0072003	0.360015
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.0072003	0.360015
3P25.3 MICRODELETION SYNDROME	0.00718862	0.359431
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0071483	0.357415
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0071483	0.357415
THYROID HEMIAGENESIS	0.007105	0.35525
PERIPHERAL HYPOTHYROIDISM	0.007105	0.35525
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.007105	0.35525
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.007105	0.35525
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007105	0.35525
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007105	0.35525
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.007105	0.35525
THYROID ECTOPIA	0.007105	0.35525
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007105	0.35525
ATHYREOSIS	0.007105	0.35525
THYROID HYPOPLASIA	0.007105	0.35525
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007105	0.35525
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.007105	0.35525
FAMILIAL THYROID DYSHORMONOGENESIS	0.007105	0.35525
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.007105	0.35525
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.007105	0.35525
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007105	0.35525
MARSHALL-SMITH SYNDROME; MRSHSS	0.00710048	0.355024
MENTAL RETARDATION, X-LINKED 104; MRX104	0.00709328	0.35466400000000003
ADENYLOSUCCINASE DEFICIENCY	0.00709328	0.35466400000000003
DYSOSTEOSCLEROSIS	0.00704225	0.3521125
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00704225	0.3521125
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00704225	0.3521125
2Q37 MONOSOMY	0.00704225	0.3521125
NEURALGIC AMYOTROPHY	0.00704225	0.3521125
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00704225	0.3521125
FAMILIAL VISCERAL MYOPATHY	0.00704225	0.3521125
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00704225	0.3521125
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.00704225	0.3521125
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00704225	0.3521125
BRACHYDACTYLY, TYPE E	0.00704225	0.3521125
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00704225	0.3521125
BARTH SYNDROME; BTHS	0.00704225	0.3521125
CHERUBISM	0.00704225	0.3521125
ACROMICRIC DYSPLASIA	0.00704225	0.3521125
RING CHROMOSOME 1 SYNDROME	0.00704225	0.3521125
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00704225	0.3521125
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00704225	0.3521125
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00704225	0.3521125
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00704225	0.3521125
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00704225	0.3521125
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.3521125
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00704225	0.3521125
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00687572	0.343786
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.006837070000000001	0.34185350000000003
MEND SYNDROME	0.006837070000000001	0.34185350000000003
PROTEUS SYNDROME	0.00674927	0.33746349999999997
KEUTEL SYNDROME	0.00674927	0.33746349999999997
2P15P16.1 MICRODELETION SYNDROME	0.00670981	0.3354905
STURGE-WEBER SYNDROME	0.00670981	0.3354905
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.00670981	0.3354905
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00670981	0.3354905
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00670981	0.3354905
INCONTINENTIA PIGMENTI	0.00670981	0.3354905
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0066595099999999996	0.3329755
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0066216700000000005	0.33108350000000003
WAARDENBURG SYNDROME TYPE 1	0.0066216700000000005	0.33108350000000003
OPTIC PATHWAY GLIOMA	0.0066216700000000005	0.33108350000000003
NON-DISTAL MONOSOMY 10Q	0.0066216700000000005	0.33108350000000003
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.0066216700000000005	0.33108350000000003
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00661951	0.33097550000000003
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00661951	0.33097550000000003
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0066195099999999995	0.3309755
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00657895	0.3289475
ABRUZZO-ERICKSON SYNDROME	0.00657895	0.3289475
KYPHOMELIC DYSPLASIA	0.00657895	0.3289475
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00657895	0.3289475
AL-RAQAD SYNDROME; ARS	0.00657895	0.3289475
ACHONDROGENESIS TYPE 1A	0.00657895	0.3289475
ACHONDROGENESIS	0.00657895	0.3289475
ACHONDROGENESIS TYPE 2	0.00657895	0.3289475
ACHONDROGENESIS TYPE 1B	0.00657895	0.3289475
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00657895	0.3289475
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00657895	0.3289475
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00657895	0.3289475
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00657895	0.3289475
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00657895	0.3289475
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.00657895	0.3289475
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00657895	0.3289475
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00657895	0.3289475
PEROXISOME BIOGENESIS DISORDER 3B	0.00657895	0.3289475
LETHAL KNIEST-LIKE DYSPLASIA	0.00657895	0.3289475
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00657895	0.3289475
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00657895	0.3289475
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00657895	0.3289475
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00657895	0.3289475
C SYNDROME	0.0065409	0.327045
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00649351	0.3246755
RUSSELL-SILVER SYNDROME, X-LINKED	0.00649351	0.3246755
ALAGILLE SYNDROME 2	0.00649351	0.3246755
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00649351	0.3246755
PARTINGTON SYNDROME	0.00649351	0.3246755
SHORT STATURE, BRUSSELS TYPE	0.00649351	0.3246755
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00649351	0.3246755
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00649351	0.3246755
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00649351	0.3246755
MEVALONIC ACIDURIA; MEVA	0.00649351	0.3246755
MEVALONIC ACIDURIA	0.00649351	0.3246755
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00649351	0.3246755
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00649351	0.3246755
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00649351	0.3246755
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00649351	0.3246755
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00649351	0.3246755
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.00649351	0.3246755
3-HYDROXYISOBUTYRIC ACIDURIA	0.00649351	0.3246755
OSTEOGENESIS IMPERFECTA, TYPE X	0.00649351	0.3246755
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00649351	0.3246755
BRUCK SYNDROME	0.00649351	0.3246755
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00649351	0.3246755
RUIJS-AALFS SYNDROME; RJALS	0.00649351	0.3246755
WOODHOUSE-SAKATI SYNDROME	0.00649351	0.3246755
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.00649351	0.3246755
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00649351	0.3246755
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00649351	0.3246755
MEIER-GORLIN SYNDROME 5; MGORS5	0.00649351	0.3246755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00649351	0.3246755
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00649351	0.3246755
MEIER-GORLIN SYNDROME 3; MGORS3	0.00649351	0.3246755
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00649351	0.3246755
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00649351	0.3246755
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00649351	0.3246755
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00649351	0.3246755
WOODHOUSE-SAKATI SYNDROME	0.00649351	0.3246755
3Q27.3 MICRODELETION SYNDROME	0.00649351	0.3246755
WOLCOTT-RALLISON SYNDROME	0.00649351	0.3246755
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00649351	0.3246755
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00649351	0.3246755
CHROMOSOME 15Q25 DELETION SYNDROME	0.0064536	0.32268
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0064536	0.32268
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0064536	0.32268
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00645161	0.3225805
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00645161	0.3225805
WISKOTT-ALDRICH SYNDROME	0.00645161	0.3225805
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00645161	0.3225805
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00645161	0.3225805
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00645161	0.3225805
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00645161	0.3225805
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00645161	0.3225805
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00645161	0.3225805
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00645161	0.3225805
FILIPPI SYNDROME	0.00645161	0.3225805
LISSENCEPHALY, X-LINKED, 2	0.00645161	0.3225805
WALKER-WARBURG SYNDROME	0.00645161	0.3225805
MICROPHTHALMIA, SYNDROMIC 3	0.00645161	0.3225805
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00645161	0.3225805
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00645161	0.3225805
CHILDHOOD APRAXIA OF SPEECH	0.00645161	0.3225805
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00645161	0.3225805
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00645161	0.3225805
LATHOSTEROLOSIS	0.00645161	0.3225805
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00645161	0.3225805
VELOCARDIOFACIAL SYNDROME	0.00645161	0.3225805
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.00645161	0.3225805
MUSICAL PERFECT PITCH	0.00645161	0.3225805
GRANGE SYNDROME	0.00645161	0.3225805
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.00645161	0.3225805
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00645161	0.3225805
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.00645161	0.3225805
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00645161	0.3225805
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00645161	0.3225805
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00645161	0.3225805
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.00645161	0.3225805
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00645161	0.3225805
ISOLATED CLEFT LIP	0.00645161	0.3225805
DUCHENNE MUSCULAR DYSTROPHY	0.00645161	0.3225805
CHAR SYNDROME	0.00642773	0.3213865
BRANCHIOOCULOFACIAL SYNDROME	0.00642773	0.3213865
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00642773	0.3213865
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	0.320513
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00641026	0.320513
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00641026	0.320513
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00641026	0.320513
TETRASOMY 18P	0.00641026	0.320513
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00641026	0.320513
JOHNSON NEUROECTODERMAL SYNDROME	0.00641026	0.320513
MULTIPLE SYNOSTOSES SYNDROME	0.00641026	0.320513
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00641026	0.320513
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00641026	0.320513
DEAFNESS-CRANIOFACIAL SYNDROME	0.00641026	0.320513
DEAFNESS-CRANIOFACIAL SYNDROME	0.00641026	0.320513
ISOLATED KLIPPEL-FEIL SYNDROME	0.00641026	0.320513
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00641026	0.320513
GOLDENHAR SYNDROME	0.00641026	0.320513
ISOLATED HEMIHYPERPLASIA	0.00641026	0.320513
GORDON SYNDROME	0.00641026	0.320513
WILDERVANCK SYNDROME	0.00641026	0.320513
HEMIFACIAL HYPERPLASIA	0.00641026	0.320513
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	0.320513
DISTAL TRISOMY 15Q	0.00641026	0.320513
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.00641026	0.320513
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	0.320513
LINEAR NEVUS SEBACEUS SYNDROME	0.00641026	0.320513
OCULOCEREBROCUTANEOUS SYNDROME	0.00641026	0.320513
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	0.320513
AICARDI SYNDROME; AIC	0.00641026	0.320513
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00641026	0.320513
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	0.320513
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	0.320513
AURICULOCONDYLAR SYNDROME	0.00641026	0.320513
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00641026	0.320513
CLAPO SYNDROME	0.00641026	0.320513
WILDERVANCK SYNDROME	0.00641026	0.320513
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00641026	0.320513
BRANCHIOOTIC SYNDROME	0.00641026	0.320513
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	0.320513
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00641026	0.320513
POLYCYSTIC KIDNEY DISEASE 2	0.00641026	0.320513
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00641026	0.320513
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00641026	0.320513
TORTICOLLIS	0.00641026	0.320513
RING CHROMOSOME 13 SYNDROME	0.006403300000000001	0.32016500000000003
NOONAN SYNDROME 5; NS5	0.0064033	0.320165
ROIFMAN-CHITAYAT SYNDROME	0.0064033	0.320165
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0064033	0.320165
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0064033	0.320165
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.0064033	0.320165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0064033	0.320165
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00637539	0.3187695
BARDET-BIEDL SYNDROME 21; BBS21	0.00637539	0.3187695
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00636546	0.318273
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00636546	0.318273
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00636546	0.318273
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00636546	0.318273
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00636546	0.318273
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00636546	0.318273
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00636546	0.318273
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00636546	0.318273
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00636546	0.318273
20P13 MICRODELETION SYNDROME	0.00636546	0.318273
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00636546	0.318273
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00636546	0.318273
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006284690000000001	0.3142345
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00627046	0.313523
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00627046	0.313523
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00627046	0.313523
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00627046	0.313523
JOUBERT SYNDROME	0.00627046	0.313523
JOUBERT SYNDROME WITH RENAL DEFECT	0.00627046	0.313523
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00627046	0.313523
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00627046	0.313523
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00627046	0.313523
ALPHA-MANNOSIDOSIS	0.00624683	0.3123415
FRANK-TER HAAR SYNDROME	0.00624683	0.3123415
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00624683	0.3123415
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00624683	0.3123415
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00624683	0.3123415
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00624683	0.3123415
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00621118	0.31055900000000003
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00621118	0.31055900000000003
X-LINKED EHLERS-DANLOS SYNDROME	0.00621118	0.31055900000000003
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00621118	0.31055900000000003
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00621118	0.31055900000000003
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00621118	0.31055900000000003
PSEUDOACHONDROPLASIA	0.00621118	0.31055900000000003
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00621118	0.31055900000000003
ACROGERIA	0.00621118	0.31055900000000003
NAIL-PATELLA SYNDROME	0.00621118	0.31055900000000003
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00621118	0.31055900000000003
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00621118	0.31055900000000003
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00621118	0.31055900000000003
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00621118	0.31055900000000003
ALDH18A1-RELATED DE BARSY SYNDROME	0.00621118	0.31055900000000003
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00621118	0.31055900000000003
COENZYME Q10 DEFICIENCY	0.00621118	0.31055900000000003
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00621118	0.31055900000000003
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00621118	0.31055900000000003
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00621118	0.31055900000000003
HYPOCHONDROPLASIA	0.00621118	0.31055900000000003
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00621118	0.31055900000000003
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00621118	0.31055900000000003
COLE-CARPENTER SYNDROME	0.00621118	0.31055900000000003
FRYNS-SMEETS-THIRY SYNDROME	0.00621118	0.31055900000000003
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00621118	0.31055900000000003
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00621118	0.31055900000000003
GERODERMA OSTEODYSPLASTICA	0.00621118	0.31055900000000003
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00621118	0.31055900000000003
BRACHYDACTYLY TYPE E	0.00621118	0.31055900000000003
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00621118	0.31055900000000003
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00615918	0.307959
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00615918	0.307959
MOMO SYNDROME	0.0061407	0.307035
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0061407	0.307035
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0060142500000000005	0.30071250000000005
ARTERIAL TORTUOSITY SYNDROME	0.0060142500000000005	0.30071250000000005
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0060142500000000005	0.30071250000000005
LOEYS-DIETZ SYNDROME 3; LDS3	0.0060142500000000005	0.30071250000000005
SHASHI-PENA SYNDROME; SHAPNS	0.0060142500000000005	0.30071250000000005
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.0060142500000000005	0.30071250000000005
CHROMOSOME 1P35 DELETION SYNDROME	0.0060142500000000005	0.30071250000000005
MUCOLIPIDOSIS III GAMMA	0.00600271	0.3001355
GLYCEROL KINASE DEFICIENCY; GKD	0.005924489999999999	0.29622449999999995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.005924489999999999	0.29622449999999995
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.00584795	0.29239750000000003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00584795	0.29239750000000003
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.00584795	0.29239750000000003
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00584795	0.29239750000000003
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00584795	0.29239750000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.00584795	0.29239750000000003
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00584795	0.29239750000000003
SCHIZOPHRENIA 15; SCZD15	0.00584795	0.29239750000000003
COFFIN-SIRIS SYNDROME 8; CSS8	0.00584795	0.29239750000000003
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00584795	0.29239750000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00584795	0.29239750000000003
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00584795	0.29239750000000003
JOUBERT SYNDROME 1	0.00584795	0.29239750000000003
LENNOX-GASTAUT SYNDROME	0.00584795	0.29239750000000003
GLYCINE ENCEPHALOPATHY; GCE	0.00584795	0.29239750000000003
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00584795	0.29239750000000003
HYPERPROLINEMIA, TYPE I	0.00584795	0.29239750000000003
MENTAL RETARDATION, X-LINKED 77	0.00584795	0.29239750000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00584795	0.29239750000000003
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00584795	0.29239750000000003
NIJMEGEN BREAKAGE SYNDROME	0.00584795	0.29239750000000003
XQ25 MICRODUPLICATION SYNDROME	0.00584795	0.29239750000000003
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00584795	0.29239750000000003
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00584795	0.29239750000000003
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.00584795	0.29239750000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00584795	0.29239750000000003
JUVENILE HUNTINGTON DISEASE	0.00584795	0.29239750000000003
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00584795	0.29239750000000003
SMITH-MAGENIS SYNDROME	0.00584795	0.29239750000000003
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.00584795	0.29239750000000003
CITRULLINEMIA TYPE II	0.00584795	0.29239750000000003
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00584795	0.29239750000000003
XQ25 DUPLICATION SYNDROME	0.00584795	0.29239750000000003
MEND SYNDROME; MEND	0.00584795	0.29239750000000003
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.00584795	0.29239750000000003
8P23.1 DELETION SYNDROME	0.00584795	0.29239750000000003
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.00584795	0.29239750000000003
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.00584795	0.29239750000000003
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.005805879999999999	0.29029399999999994
X SMALL RINGS	0.0057680200000000004	0.288401
MACROCEPHALY/AUTISM SYNDROME	0.00563039	0.2815195
CHUDLEY-LOWRY-HOAR SYNDROME	0.00563039	0.2815195
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00546448	0.27322399999999997
CLASSIC PHENYLKETONURIA	0.00546448	0.27322399999999997
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00546448	0.27322399999999997
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00546448	0.27322399999999997
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00546448	0.27322399999999997
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00546448	0.27322399999999997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.00546448	0.27322399999999997
PANDAS	0.00546448	0.27322399999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.00546448	0.27322399999999997
TRISOMY 18P	0.00546448	0.27322399999999997
8Q12 MICRODUPLICATION SYNDROME	0.00546448	0.27322399999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.00546448	0.27322399999999997
MOHR-TRANEBJAERG SYNDROME	0.00546448	0.27322399999999997
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.00546448	0.27322399999999997
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.27322399999999997
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.00546448	0.27322399999999997
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.00546448	0.27322399999999997
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.27322399999999997
MICROTIA	0.00546448	0.27322399999999997
TRANSKETOLASE DEFICIENCY	0.00546448	0.27322399999999997
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.27322399999999997
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00546448	0.27322399999999997
SPINOCEREBELLAR ATAXIA 14	0.00546448	0.27322399999999997
RECESSIVE X-LINKED ICHTHYOSIS	0.00546448	0.27322399999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00546448	0.27322399999999997
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00546448	0.27322399999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.00546448	0.27322399999999997
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.00546448	0.27322399999999997
ADRENOLEUKODYSTROPHY	0.00546448	0.27322399999999997
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.00546448	0.27322399999999997
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00546448	0.27322399999999997
MYOCLONIC EPILEPSY OF INFANCY	0.00546448	0.27322399999999997
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.27322399999999997
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00546448	0.27322399999999997
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00546448	0.27322399999999997
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00546448	0.27322399999999997
PHENYLKETONURIA	0.00546448	0.27322399999999997
JOUBERT SYNDROME 35; JBTS35	0.00541418	0.27070900000000003
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00541418	0.27070900000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00541418	0.27070900000000003
GAUCHER DISEASE	0.00537756	0.268878
MANGANESE POISONING	0.00537634	0.26881700000000003
HODGKIN LYMPHOMA	0.00537634	0.26881700000000003
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.26881700000000003
MARSILI SYNDROME; MARSIS	0.00537634	0.26881700000000003
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00537634	0.26881700000000003
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.26881700000000003
INTERNAL CAROTID AGENESIS	0.00537634	0.26881700000000003
BENIGN OCCIPITAL EPILEPSY	0.00537634	0.26881700000000003
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.26881700000000003
POSTENCEPHALITIC PARKINSONISM	0.00537634	0.26881700000000003
LYME DISEASE	0.00537634	0.26881700000000003
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.26881700000000003
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.26881700000000003
PITUITARY CARCINOMA	0.00537634	0.26881700000000003
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.26881700000000003
LUJO HEMORRHAGIC FEVER	0.00537634	0.26881700000000003
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.26881700000000003
PARIETAL FORAMINA	0.00537634	0.26881700000000003
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.26881700000000003
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00537634	0.26881700000000003
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.26881700000000003
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.26881700000000003
TEMPI SYNDROME	0.00537634	0.26881700000000003
PAPILLOMA OF CHOROID PLEXUS	0.00537634	0.26881700000000003
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.26881700000000003
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00537634	0.26881700000000003
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.26881700000000003
RAT-BITE FEVER	0.00537634	0.26881700000000003
9Q SUBTELOMERIC DELETION SYNDROME	0.00537634	0.26881700000000003
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.26881700000000003
PARKES WEBER SYNDROME	0.00537634	0.26881700000000003
NOCARDIOSIS	0.00537634	0.26881700000000003
PONTIAC FEVER	0.00537634	0.26881700000000003
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.26881700000000003
L1 SYNDROME	0.00537634	0.26881700000000003
PROLACTINOMA	0.00537634	0.26881700000000003
IDIOPATHIC PANUVEITIS	0.00537634	0.26881700000000003
CHIARI MALFORMATION TYPE I	0.00537634	0.26881700000000003
ADENOHYPOPHYSITIS	0.00537634	0.26881700000000003
CAMURATI-ENGELMANN DISEASE	0.00537634	0.26881700000000003
NEUROFIBROMATOSIS, TYPE II	0.00537634	0.26881700000000003
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.26881700000000003
SOLAR URTICARIA	0.00537634	0.26881700000000003
ENCEPHALITIS LETHARGICA	0.00537634	0.26881700000000003
NIPAH VIRUS DISEASE	0.00537634	0.26881700000000003
SYDENHAM CHOREA	0.00537634	0.26881700000000003
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00537634	0.26881700000000003
SNEDDON SYNDROME	0.00537634	0.26881700000000003
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.26881700000000003
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00537634	0.26881700000000003
TSH-SECRETING PITUITARY ADENOMA	0.00537634	0.26881700000000003
BRUNNER SYNDROME; BRNRS	0.00537634	0.26881700000000003
PIEBALDISM	0.00537634	0.26881700000000003
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.26881700000000003
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00537634	0.26881700000000003
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00537634	0.26881700000000003
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.26881700000000003
PANHYPOPHYSITIS	0.00537634	0.26881700000000003
NON-FUNCTIONING PITUITARY ADENOMA	0.00537634	0.26881700000000003
COLD AGGLUTININ DISEASE	0.00537634	0.26881700000000003
RIFT VALLEY FEVER	0.00537634	0.26881700000000003
EVEN-PLUS SYNDROME	0.00537634	0.26881700000000003
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00537634	0.26881700000000003
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.26881700000000003
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.26881700000000003
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00537634	0.26881700000000003
HYDROXYKYNURENINURIA	0.00537634	0.26881700000000003
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00537634	0.26881700000000003
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.00537634	0.26881700000000003
AICARDI-GOUTIÈRES SYNDROME	0.00537634	0.26881700000000003
HUGHES-STOVIN SYNDROME	0.00537634	0.26881700000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.26881700000000003
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.26881700000000003
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.26881700000000003
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.26881700000000003
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.26881700000000003
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.26881700000000003
HOLOPROSENCEPHALY 11	0.00537634	0.26881700000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.26881700000000003
MEDULLOBLASTOMA	0.00537634	0.26881700000000003
NARP SYNDROME	0.00537634	0.26881700000000003
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00537634	0.26881700000000003
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.26881700000000003
LHERMITTE-DUCLOS DISEASE	0.00537634	0.26881700000000003
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00537634	0.26881700000000003
NON-DISTAL TRISOMY 13Q	0.00537634	0.26881700000000003
SEVERE HEMOPHILIA A	0.00537634	0.26881700000000003
CENTRAL DIABETES INSIPIDUS	0.00537634	0.26881700000000003
GLIOBLASTOMA	0.00537634	0.26881700000000003
ROSAÏ-DORFMAN DISEASE	0.00537634	0.26881700000000003
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.26881700000000003
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00537634	0.26881700000000003
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.26881700000000003
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.26881700000000003
BABESIOSIS	0.00537634	0.26881700000000003
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.26881700000000003
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.26881700000000003
THYMIC TUMOR	0.00537634	0.26881700000000003
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00537634	0.26881700000000003
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.26881700000000003
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.26881700000000003
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00537634	0.26881700000000003
ISOLATED TRIGONOCEPHALY	0.00537634	0.26881700000000003
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.26881700000000003
PRIMARY CILIARY DYSKINESIA	0.00537634	0.26881700000000003
LAFORA DISEASE	0.00537634	0.26881700000000003
HEMANGIOBLASTOMA	0.00537634	0.26881700000000003
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.26881700000000003
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.26881700000000003
GANGLIOCYTOMA	0.00537634	0.26881700000000003
MALARIA	0.00537634	0.26881700000000003
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.26881700000000003
PINEOCYTOMA	0.00537634	0.26881700000000003
MAJEED SYNDROME	0.00537634	0.26881700000000003
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.26881700000000003
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.26881700000000003
PITUICYTOMA	0.00537634	0.26881700000000003
CENTRAL NEUROCYTOMA	0.00537634	0.26881700000000003
EPISODIC ATAXIA, TYPE 3	0.00537634	0.26881700000000003
GOLDBERG-SHPRINTZEN SYNDROME	0.00537634	0.26881700000000003
FAMILIAL THROMBOCYTOSIS	0.00537634	0.26881700000000003
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00529557	0.2647785
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00529557	0.2647785
XQ28 (MECP2) DUPLICATION	0.00529557	0.2647785
CRANIODIAPHYSEAL DYSPLASIA	0.0052577100000000005	0.26288550000000005
MULTIPLE SULFATASE DEFICIENCY	0.0052577100000000005	0.26288550000000005
COFFIN-SIRIS SYNDROME 5	0.0052577100000000005	0.26288550000000005
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.0052577100000000005	0.26288550000000005
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0052577100000000005	0.26288550000000005
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.0052577100000000005	0.26288550000000005
CARPENTER-WAZIRI SYNDROME	0.0052577100000000005	0.26288550000000005
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0052577100000000005	0.26288550000000005
OGDEN SYNDROME; OGDNS	0.0052577100000000005	0.26288550000000005
268650 RUDIGER SYNDROME	0.0052577100000000005	0.26288550000000005
DONNAI-BARROW SYNDROME	0.0051824	0.25912
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0051824	0.25912
CHROMOSOME 9P DELETION SYNDROME	0.0051824	0.25912
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0051824	0.25912
NOONAN SYNDROME 6; NS6	0.0051824	0.25912
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00515158	0.257579
LAURENCE-MOON SYNDROME	0.00515158	0.257579
URBAN-ROGERS-MEYER SYNDROME	0.00515158	0.257579
SENIOR-LOKEN SYNDROME 9	0.00515158	0.257579
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00515158	0.257579
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00515158	0.257579
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00515158	0.257579
XQ21 MICRODELETION SYNDROME	0.00515158	0.257579
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00502513	0.2512565
OTOFACIOCERVICAL SYNDROME	0.00502513	0.2512565
OTODENTAL DYSPLASIA	0.00502513	0.2512565
LELIS SYNDROME	0.00502513	0.2512565
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00502513	0.2512565
OTODENTAL SYNDROME	0.00502513	0.2512565
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00502513	0.2512565
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00502513	0.2512565
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00502513	0.2512565
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00502513	0.2512565
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00502513	0.2512565
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00502513	0.2512565
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00502513	0.2512565
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00502513	0.2512565
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00502513	0.2512565
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.00502513	0.2512565
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00502513	0.2512565
MENTAL RETARDATION, X-LINKED 93	0.00502513	0.2512565
19Q13.11 MICRODELETION SYNDROME	0.00502513	0.2512565
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00502513	0.2512565
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00502513	0.2512565
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.00502513	0.2512565
RING CHROMOSOME 22 SYNDROME	0.00502513	0.2512565
CAP MYOPATHY	0.00502513	0.2512565
RAPADILINO SYNDROME	0.00502513	0.2512565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00502513	0.2512565
15Q14 MICRODELETION SYNDROME	0.00502513	0.2512565
CHROMOSOME 16P13.2 DELETION SYNDROME	0.00493537	0.24676849999999997
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00493537	0.24676849999999997
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00493537	0.24676849999999997
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00493537	0.24676849999999997
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00493537	0.24676849999999997
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00493537	0.24676849999999997
ALG11-CDG	0.00493537	0.24676849999999997
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00493537	0.24676849999999997
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00493537	0.24676849999999997
SSR4-CDG	0.00493537	0.24676849999999997
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00493537	0.24676849999999997
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00493537	0.24676849999999997
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00493537	0.24676849999999997
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00493537	0.24676849999999997
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00493537	0.24676849999999997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00493537	0.24676849999999997
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00493537	0.24676849999999997
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00489537	0.24476849999999997
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00489537	0.24476849999999997
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00481676	0.240838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00481676	0.240838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00481676	0.240838
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00481676	0.240838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00481676	0.240838
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.0047789	0.238945
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0047789	0.238945
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0047789	0.238945
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.0047789	0.238945
MUCOLIPIDOSIS TYPE IV	0.0047789	0.238945
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0047035900000000005	0.23517950000000004
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.0047035900000000005	0.23517950000000004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0047035900000000005	0.23517950000000004
HYPERTRYPTOPHANEMIA; HYPTRP	0.0047035900000000005	0.23517950000000004
OCULODENTODIGITAL DYSPLASIA	0.0047035900000000005	0.23517950000000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00467916	0.233958
VERVERI-BRADY SYNDROME; VERBRAS	0.00467916	0.233958
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00467916	0.233958
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00467916	0.233958
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00467916	0.233958
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00467916	0.233958
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00467916	0.233958
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00467916	0.233958
CONO-SPONDYLAR DYSPLASIA	0.00467916	0.233958
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00467916	0.233958
SYNDROMIC DIARRHEA	0.00467916	0.233958
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00467916	0.233958
CEREBROFACIOARTICULAR SYNDROME	0.00467916	0.233958
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00467916	0.233958
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00467916	0.233958
COG1-CDG	0.00467916	0.233958
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00467916	0.233958
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00467916	0.233958
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00467916	0.233958
ATELOSTEOGENESIS TYPE II	0.00467916	0.233958
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00467916	0.233958
49,XXXYY SYNDROME	0.00467916	0.233958
7P22.1 MICRODUPLICATION SYNDROME	0.00467916	0.233958
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00456055	0.2280275
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00456055	0.2280275
AUTISM, SUSCEPTIBILITY TO, 18	0.00456055	0.2280275
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.00456055	0.2280275
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00456055	0.2280275
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00456055	0.2280275
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00452269	0.22613450000000002
49,XYYYY SYNDROME	0.00452269	0.22613450000000002
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00452269	0.22613450000000002
NF1-MICRODELETION SYNDROME	0.00452269	0.22613450000000002
FRYNS SYNDROME	0.00452269	0.22613450000000002
FRANK-TER HAAR SYNDROME; FTHS	0.00452269	0.22613450000000002
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00452269	0.22613450000000002
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00452269	0.22613450000000002
GENITOPATELLAR SYNDROME	0.00452269	0.22613450000000002
SCHINZEL-GIEDION SYNDROME	0.00452269	0.22613450000000002
SIFRIM-HITZ-WEISS SYNDROME	0.00452269	0.22613450000000002
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.00419328	0.209664
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00419328	0.209664
ABLEPHARON MACROSTOMIA SYNDROME	0.00419328	0.209664
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00419328	0.209664
STICKLER SYNDROME, TYPE I	0.00419328	0.209664
EHLERS-DANLOS SYNDROME, TYPE VI	0.00419328	0.209664
CONGENITAL PANCREATIC CYST	0.00413223	0.20661149999999998
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00413223	0.20661149999999998
GRAFT VERSUS HOST DISEASE	0.00413223	0.20661149999999998
MYXOID/ROUND CELL LIPOSARCOMA	0.00413223	0.20661149999999998
DESMOID TUMOR	0.00413223	0.20661149999999998
HEPATOCELLULAR CARCINOMA	0.00413223	0.20661149999999998
NEPHROBLASTOMA	0.00413223	0.20661149999999998
FAMILIAL PROGRESSIVE CARDIAC CONDUCTION DEFECT	0.00413223	0.20661149999999998
CONGENITAL PRIMARY MEGAURETER	0.00413223	0.20661149999999998
WHIPPLE DISEASE	0.00413223	0.20661149999999998
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00413223	0.20661149999999998
CHRONIC GRAFT VERSUS HOST DISEASE	0.00413223	0.20661149999999998
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00413223	0.20661149999999998
OVARIAN FIBROMA	0.00413223	0.20661149999999998
PANCREATOBLASTOMA	0.00413223	0.20661149999999998
STEVENS-JOHNSON SYNDROME	0.00413223	0.20661149999999998
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00413223	0.20661149999999998
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00413223	0.20661149999999998
SAPHO SYNDROME	0.00413223	0.20661149999999998
LIPOSARCOMA	0.00413223	0.20661149999999998
ERDHEIM-CHESTER DISEASE	0.00413223	0.20661149999999998
AA AMYLOIDOSIS	0.00413223	0.20661149999999998
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00413223	0.20661149999999998
GAUCHER DISEASE TYPE 1	0.00413223	0.20661149999999998
ADULT-ONSET STILL DISEASE	0.00413223	0.20661149999999998
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.00413223	0.20661149999999998
ROTOR SYNDROME	0.00413223	0.20661149999999998
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00413223	0.20661149999999998
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00413223	0.20661149999999998
MICROSCOPIC POLYANGIITIS	0.00413223	0.20661149999999998
CRYOGLOBULINEMIC VASCULITIS	0.00413223	0.20661149999999998
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00413223	0.20661149999999998
CONGENITAL FIBRINOGEN DEFICIENCY	0.00413223	0.20661149999999998
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00413223	0.20661149999999998
HEREDITARY ANGIOEDEMA	0.00413223	0.20661149999999998
ACQUIRED ANGIOEDEMA	0.00413223	0.20661149999999998
JUVENILE IDIOPATHIC ARTHRITIS	0.00413223	0.20661149999999998
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00413223	0.20661149999999998
HEREDITARY SPHEROCYTOSIS	0.00413223	0.20661149999999998
TETANUS	0.00413223	0.20661149999999998
PRIMARY EFFUSION LYMPHOMA	0.00413223	0.20661149999999998
ACUTE PROMYELOCYTIC LEUKEMIA	0.00413223	0.20661149999999998
GCGR-RELATED HYPERGLUCAGONEMIA	0.00413223	0.20661149999999998
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00413223	0.20661149999999998
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.00413223	0.20661149999999998
CHOLANGIOCARCINOMA	0.00413223	0.20661149999999998
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00413223	0.20661149999999998
MALAKOPLAKIA	0.00413223	0.20661149999999998
BURKITT LYMPHOMA	0.00413223	0.20661149999999998
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00413223	0.20661149999999998
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.00413223	0.20661149999999998
ADENOCARCINOMA OF THE ANAL CANAL	0.00413223	0.20661149999999998
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.00413223	0.20661149999999998
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.00413223	0.20661149999999998
PLUMMER-VINSON SYNDROME	0.00413223	0.20661149999999998
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00413223	0.20661149999999998
LYMPHANGIOLEIOMYOMATOSIS	0.00413223	0.20661149999999998
TOXIC EPIDERMAL NECROLYSIS	0.00413223	0.20661149999999998
CARNEY-STRATAKIS SYNDROME	0.00413223	0.20661149999999998
TANGIER DISEASE	0.00413223	0.20661149999999998
HEREDITARY CHRONIC PANCREATITIS	0.00413223	0.20661149999999998
KLATSKIN TUMOR	0.00413223	0.20661149999999998
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00413223	0.20661149999999998
SMALL CELL CARCINOMA OF THE BLADDER	0.00413223	0.20661149999999998
CASTLEMAN DISEASE	0.00413223	0.20661149999999998
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00413223	0.20661149999999998
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00413223	0.20661149999999998
SICKLE CELL ANEMIA	0.00413223	0.20661149999999998
ALPHA-HEAVY CHAIN DISEASE	0.00413223	0.20661149999999998
HEREDITARY ANGIOEDEMA TYPE 1	0.00413223	0.20661149999999998
EOSINOPHILIC GASTROENTERITIS	0.00413223	0.20661149999999998
NEUROENDOCRINE TUMOR OF THE COLON	0.00413223	0.20661149999999998
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00413223	0.20661149999999998
CYCLIC NEUTROPENIA	0.00413223	0.20661149999999998
PEUTZ-JEGHERS SYNDROME	0.00413223	0.20661149999999998
AUTOIMMUNE HEPATITIS	0.00413223	0.20661149999999998
OVARIAN HYPERSTIMULATION SYNDROME	0.00413223	0.20661149999999998
TROPICAL CALCIFIC PANCREATITIS	0.00413223	0.20661149999999998
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00413223	0.20661149999999998
PANCREATITIS, HEREDITARY	0.00413223	0.20661149999999998
YAO SYNDROME	0.00413223	0.20661149999999998
BUDD-CHIARI SYNDROME	0.00413223	0.20661149999999998
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00413223	0.20661149999999998
MICROSPORIDIOSIS	0.00413223	0.20661149999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00413223	0.20661149999999998
LACTOSE INTOLERANCE, ADULT TYPE	0.00413223	0.20661149999999998
FAMILIAL PANCREATIC CARCINOMA	0.00413223	0.20661149999999998
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.00413223	0.20661149999999998
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00413223	0.20661149999999998
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00413223	0.20661149999999998
HEMOCHROMATOSIS TYPE 4	0.00413223	0.20661149999999998
DUBIN-JOHNSON SYNDROME	0.00413223	0.20661149999999998
MÉNÉTRIER DISEASE	0.00413223	0.20661149999999998
CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENTOF DIAPHRAGM	0.00413223	0.20661149999999998
TREHALASE DEFICIENCY	0.00413223	0.20661149999999998
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00413223	0.20661149999999998
SITOSTEROLEMIA	0.00413223	0.20661149999999998
ISOLATED POLYCYSTIC LIVER DISEASE	0.00413223	0.20661149999999998
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00413223	0.20661149999999998
REACTIVE ARTHRITIS	0.00413223	0.20661149999999998
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00413223	0.20661149999999998
PRIMARY SCLEROSING CHOLANGITIS	0.00413223	0.20661149999999998
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00413223	0.20661149999999998
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00413223	0.20661149999999998
POLYEMBRYOMA	0.00413223	0.20661149999999998
INFUNDIBULOPELVIC DYSGENESIS	0.00413223	0.20661149999999998
SYSTEMIC CAPILLARY LEAK SYNDROME	0.00413223	0.20661149999999998
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00413223	0.20661149999999998
MALIGNANT PERITONEAL MESOTHELIOMA	0.00413223	0.20661149999999998
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.00413223	0.20661149999999998
HEREDITARY ELLIPTOCYTOSIS	0.00413223	0.20661149999999998
CRONKHITE-CANADA SYNDROME	0.00413223	0.20661149999999998
INFLAMMATORY BOWEL DISEASE 11	0.00413223	0.20661149999999998
DENT DISEASE	0.00413223	0.20661149999999998
PEUTZ-JEGHERS SYNDROME	0.00413223	0.20661149999999998
KETAMINE-INDUCED BILIARY DILATATION	0.00413223	0.20661149999999998
HEMOCHROMATOSIS, TYPE 1	0.00413223	0.20661149999999998
SMITH-KINGSMORE SYNDROME; SKS	0.00395859	0.19792949999999998
PELGER-HUET ANOMALY; PHA	0.00395859	0.19792949999999998
CHROMOSOME 18Q DELETION SYNDROME	0.00395859	0.19792949999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00395859	0.19792949999999998
ADAMS-OLIVER SYNDROME 2; AOS2	0.00395859	0.19792949999999998
DISTAL MONOSOMY 6P	0.00395859	0.19792949999999998
JACOBSEN SYNDROME	0.00395859	0.19792949999999998
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.00395859	0.19792949999999998
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00395859	0.19792949999999998
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00395859	0.19792949999999998
BARDET-BIEDL SYNDROME 19; BBS19	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 18; BBS18	0.00390625	0.1953125
WAGR SYNDROME	0.00390625	0.1953125
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00390625	0.1953125
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00390625	0.1953125
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00390625	0.1953125
BIEMOND SYNDROME TYPE 2	0.00390625	0.1953125
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00390625	0.1953125
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.00390625	0.1953125
RETINITIS PIGMENTOSA 71; RP71	0.00390625	0.1953125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00390625	0.1953125
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00390625	0.1953125
CARPENTER SYNDROME	0.00390625	0.1953125
JOUBERT SYNDROME 8	0.00390625	0.1953125
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.00390625	0.1953125
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 11; BBS11	0.00390625	0.1953125
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 17; BBS17	0.00390625	0.1953125
ULNAR-MAMMARY SYNDROME; UMS	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 2	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 4; BBS4	0.00390625	0.1953125
TRIGLYCERIDE STORAGE DISEASE, TYPE II	0.00390625	0.1953125
ACROCEPHALOSYNDACTYLY	0.00390625	0.1953125
NARCOLEPSY 7; NRCLP7	0.00390625	0.1953125
MODY	0.00390625	0.1953125
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00390625	0.1953125
NARCOLEPSY TYPE 1	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 5; BBS5	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 7; BBS7	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 8; BBS8	0.00390625	0.1953125
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00390625	0.1953125
LEPTIN DEFICIENCY OR DYSFUNCTION	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 9; BBS9	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 10; BBS10	0.00390625	0.1953125
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00390625	0.1953125
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.00390625	0.1953125
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 12; BBS12	0.00390625	0.1953125
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.00390625	0.1953125
SUMMITT SYNDROME	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 13; BBS13	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 14; BBS14	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 16; BBS16	0.00390625	0.1953125
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.00390625	0.1953125
OBESITY-HYPOVENTILATION SYNDROME	0.00390625	0.1953125
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00390625	0.1953125
SERTOLI CELL-ONLY SYNDROME	0.00390625	0.1953125
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 3; BBS3	0.00390625	0.1953125
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	0.00390625	0.1953125
SHOX-RELATED SHORT STATURE	0.00390625	0.1953125
KALLMANN SYNDROME	0.00390625	0.1953125
DYSBETALIPOPROTEINEMIA	0.00390625	0.1953125
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00390625	0.1953125
RETINITIS PIGMENTOSA	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 6; BBS6	0.00390625	0.1953125
RING CHROMOSOME Y SYNDROME	0.00390625	0.1953125
ULNAR-MAMMARY SYNDROME	0.00390625	0.1953125
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00390625	0.1953125
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.1953125
BARDET-BIEDL SYNDROME 20	0.00390625	0.1953125
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.00390625	0.1953125
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00390625	0.1953125
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.00390625	0.1953125
3Q29 MICRODUPLICATION SYNDROME	0.00390625	0.1953125
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00390625	0.1953125
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00390625	0.1953125
OBESITY	0.00390625	0.1953125
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.1953125
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.1953125
CARCINOMA OF ESOPHAGUS	0.00390625	0.1953125
ADENOCARCINOMA OF THE ESOPHAGUS	0.00390625	0.1953125
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00390625	0.1953125
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.00390625	0.1953125
HALOTHANE HEPATITIS	0.00390625	0.1953125
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00390625	0.1953125
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.1953125
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00390625	0.1953125
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00390625	0.1953125
CENTRAL PRECOCIOUS PUBERTY	0.00390625	0.1953125
HALLERMANN-STREIFF SYNDROME	0.00371447	0.1857235
X-LINKED RECESSIVE OCULAR ALBINISM	0.00371447	0.1857235
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00371447	0.1857235
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00371447	0.1857235
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00371447	0.1857235
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00371447	0.1857235
FRONTOOCULAR SYNDROME	0.00371447	0.1857235
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00371447	0.1857235
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00371447	0.1857235
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00371447	0.1857235
MUSCLE-EYE-BRAIN DISEASE	0.00371447	0.1857235
OCULOCUTANEOUS ALBINISM	0.00371447	0.1857235
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00371447	0.1857235
MEIER-GORLIN SYNDROME 7	0.00371447	0.1857235
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00371447	0.1857235
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00371447	0.1857235
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00371447	0.1857235
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00371447	0.1857235
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00371447	0.1857235
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.00371447	0.1857235
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.00371447	0.1857235
RETINAL CONE DYSTROPHY 3B	0.00371447	0.1857235
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00371447	0.1857235
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00371447	0.1857235
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00371447	0.1857235
SENGERS SYNDROME	0.00371447	0.1857235
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00371447	0.1857235
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00371447	0.1857235
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00371447	0.1857235
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00369004	0.184502
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.184502
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.184502
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00369004	0.184502
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00369004	0.184502
OROFACIODIGITAL SYNDROME TYPE 14	0.00369004	0.184502
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00369004	0.184502
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00369004	0.184502
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.184502
PGM3-CDG	0.00369004	0.184502
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.184502
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00369004	0.184502
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.184502
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.184502
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00369004	0.184502
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00369004	0.184502
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00369004	0.184502
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00369004	0.184502
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00369004	0.184502
CAMURATI-ENGELMANN DISEASE	0.00369004	0.184502
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00369004	0.184502
CRISS-CROSS HEART	0.00369004	0.184502
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.184502
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00369004	0.184502
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00369004	0.184502
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00369004	0.184502
ESOPHAGEAL ATRESIA	0.00369004	0.184502
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.184502
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00369004	0.184502
BETA-MANNOSIDOSIS	0.00369004	0.184502
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00369004	0.184502
KLEEFSTRA SYNDROME 2; KLEFS2	0.00369004	0.184502
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.184502
TRANSALDOLASE DEFICIENCY	0.00369004	0.184502
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.184502
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.184502
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00369004	0.184502
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00369004	0.184502
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00369004	0.184502
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00369004	0.184502
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.184502
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00369004	0.184502
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00369004	0.184502
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.184502
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.184502
SÉZARY SYNDROME	0.00369004	0.184502
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.184502
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.184502
HAIRY ELBOWS	0.00369004	0.184502
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00369004	0.184502
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00369004	0.184502
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.184502
ZECHI-CEIDE SYNDROME	0.00369004	0.184502
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.184502
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00369004	0.184502
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.184502
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00369004	0.184502
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00369004	0.184502
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.184502
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.184502
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.184502
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00369004	0.184502
ISOLATED BILIARY ATRESIA	0.00369004	0.184502
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.184502
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00369004	0.184502
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.184502
601095 HARROD SYNDROME	0.00369004	0.184502
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.184502
FREE SIALIC ACID STORAGE DISEASE	0.00369004	0.184502
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00369004	0.184502
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.184502
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.184502
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.184502
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00369004	0.184502
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.184502
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00369004	0.184502
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00369004	0.184502
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.184502
RODRIGUES BLINDNESS	0.00369004	0.184502
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.184502
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00369004	0.184502
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.184502
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.184502
RETT SYNDROME; RTT	0.00357143	0.1785715
HINMAN SYNDROME	0.00357143	0.1785715
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.1785715
PAROXYSMAL EXTREME PAIN DISORDER	0.00357143	0.1785715
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.1785715
WOUND BOTULISM	0.00357143	0.1785715
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.1785715
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00357143	0.1785715
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.1785715
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00357143	0.1785715
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00357143	0.1785715
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00357143	0.1785715
PURE AUTONOMIC FAILURE	0.00357143	0.1785715
IATROGENIC BOTULISM	0.00357143	0.1785715
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00357143	0.1785715
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00357143	0.1785715
PANHYPOPITUITARISM	0.00357143	0.1785715
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00357143	0.1785715
WOLFRAM SYNDROME	0.00357143	0.1785715
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.1785715
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.1785715
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00357143	0.1785715
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.1785715
OCHOA SYNDROME	0.00357143	0.1785715
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.1785715
PROPIONIC ACIDEMIA	0.00357143	0.1785715
INHALATIONAL BOTULISM	0.00357143	0.1785715
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.1785715
MULTIPLE SYSTEM ATROPHY	0.00357143	0.1785715
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00357143	0.1785715
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.1785715
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.1785715
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.1785715
PROPIONIC ACIDEMIA	0.00357143	0.1785715
LIDDLE SYNDROME	0.00357143	0.1785715
KAPUR-TORIELLO SYNDROME	0.00357143	0.1785715
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.1785715
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.1785715
HOLOPROSENCEPHALY 2; HPE2	0.00357143	0.1785715
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00357143	0.1785715
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.1785715
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.1785715
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.1785715
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357143	0.1785715
MYXEDEMA	0.00357143	0.1785715
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.1785715
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00357143	0.1785715
RETT SYNDROME, CONGENITAL VARIANT	0.00357143	0.1785715
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.1785715
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.1785715
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.1785715
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.1785715
NEPHROGENIC DIABETES INSIPIDUS	0.00357143	0.1785715
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.1785715
ATTRV30M AMYLOIDOSIS	0.00357143	0.1785715
HYPOPHOSPHATASIA, INFANTILE	0.00357143	0.1785715
UROFACIAL SYNDROME 2	0.00357143	0.1785715
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00357143	0.1785715
INFANTILE DYSTONIA-PARKINSONISM	0.00357143	0.1785715
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.1785715
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00357143	0.1785715
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.1785715
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00357143	0.1785715
611961 STEVENSON-CAREY SYNDROME	0.00357143	0.1785715
NIEMANN-PICK DISEASE, TYPE A	0.00357143	0.1785715
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.1785715
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.1785715
FG SYNDROME 2; FGS2	0.00357143	0.1785715
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00357143	0.1785715
KAPUR-TORIELLO SYNDROME	0.00357143	0.1785715
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.1785715
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00357143	0.1785715
AICARDI SYNDROME	0.00357143	0.1785715
PRUNE BELLY SYNDROME	0.00357143	0.1785715
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.1785715
SIALIDOSIS TYPE 1	0.00353357	0.17667850000000002
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.17667850000000002
NEURAMINIDASE DEFICIENCY	0.00353357	0.17667850000000002
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00353357	0.17667850000000002
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.17667850000000002
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00353357	0.17667850000000002
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.00353357	0.17667850000000002
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00353357	0.17667850000000002
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00353357	0.17667850000000002
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.00353357	0.17667850000000002
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.17667850000000002
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00353357	0.17667850000000002
MORQUIO SYNDROME A	0.00353357	0.17667850000000002
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.17667850000000002
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00353357	0.17667850000000002
MUCOLIPIDOSIS TYPE III	0.00353357	0.17667850000000002
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00353357	0.17667850000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00353357	0.17667850000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00353357	0.17667850000000002
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.00353357	0.17667850000000002
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.17667850000000002
MENTAL RETARDATION, X-LINKED 103	0.00353357	0.17667850000000002
SIALIDOSIS TYPE 2	0.00353357	0.17667850000000002
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00353357	0.17667850000000002
GENITOPATELLAR SYNDROME; GTPTS	0.00353357	0.17667850000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.17667850000000002
X-LINKED ACROGIGANTISM	0.00353357	0.17667850000000002
CAMPOMELIA, CUMMING TYPE	0.00353357	0.17667850000000002
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.17667850000000002
FUCOSIDOSIS	0.00353357	0.17667850000000002
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00353357	0.17667850000000002
GALACTOSIALIDOSIS	0.00353357	0.17667850000000002
OGDEN SYNDROME	0.00353357	0.17667850000000002
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00353357	0.17667850000000002
FOUNTAIN SYNDROME	0.00353357	0.17667850000000002
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.17667850000000002
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00353357	0.17667850000000002
PITUITARY GIGANTISM	0.00353357	0.17667850000000002
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.17667850000000002
INFANTILE SYSTEMIC HYALINOSIS	0.00353357	0.17667850000000002
SCHEIE SYNDROME	0.00353357	0.17667850000000002
LEUKOCYTE ADHESION DEFICIENCY	0.00353357	0.17667850000000002
BECKWITH-WIEDEMANN SYNDROME	0.00353357	0.17667850000000002
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.17667850000000002
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.17667850000000002
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.17667850000000002
GASTROCUTANEOUS SYNDROME	0.00345826	0.17291299999999998
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00345826	0.17291299999999998
ACROCRANIOFACIAL DYSOSTOSIS	0.00345826	0.17291299999999998
TARP SYNDROME	0.00345826	0.17291299999999998
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00345826	0.17291299999999998
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00345826	0.17291299999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00345826	0.17291299999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00345826	0.17291299999999998
ACROMELIC FRONTONASAL DYSPLASIA	0.00345826	0.17291299999999998
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00296947	0.1484735
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00296947	0.1484735
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00296947	0.1484735
MEIER-GORLIN SYNDROME 6; MGORS6	0.00296947	0.1484735
CROSSED POLYSYNDACTYLY	0.00296947	0.1484735
DESMOSTEROLOSIS	0.00296947	0.1484735
20P12.3 MICRODELETION SYNDROME	0.0027132600000000003	0.135663
CHROMOSOME 16Q22 DELETION SYNDROME	0.0027132600000000003	0.135663
TRISOMY 1Q	0.0027132600000000003	0.135663
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0027132600000000003	0.135663
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027132600000000003	0.135663
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0027132600000000003	0.135663
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0027132600000000003	0.135663
14Q11.2 MICRODELETION SYNDROME	0.0027132600000000003	0.135663
CHAND SYNDROME	0.0027132600000000003	0.135663
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0027132600000000003	0.135663
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0027132600000000003	0.135663
RING CHROMOSOME 14 SYNDROME	0.0027132600000000003	0.135663
8P11.2 DELETION SYNDROME	0.0027132600000000003	0.135663
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0027132600000000003	0.135663
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0027132600000000003	0.135663
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.0027132600000000003	0.135663
PAI SYNDROME	0.0027132600000000003	0.135663
HARTSFIELD SYNDROME	0.0027132600000000003	0.135663
48,XYYY SYNDROME	0.0027132600000000003	0.135663
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0027132600000000003	0.135663
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0027132600000000003	0.135663
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.0027132600000000003	0.135663
RITSCHER-SCHINZEL SYNDROME 1	0.0027132600000000003	0.135663
CRANE-HEISE SYNDROME	0.0027132600000000003	0.135663
NOONAN SYNDROME 4; NS4	0.0027132600000000003	0.135663
RAINE SYNDROME	0.0027132600000000003	0.135663
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0027132600000000003	0.135663
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0027132600000000003	0.135663
FRONTONASAL DYSPLASIA 2; FND2	0.0027132600000000003	0.135663
OPSISMODYSPLASIA; OPSMD	0.0027132600000000003	0.135663
FRONTOFACIONASAL DYSPLASIA	0.0027132600000000003	0.135663
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0027132600000000003	0.135663
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0027132600000000003	0.135663
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0027132600000000003	0.135663
NASODIGITOACOUSTIC SYNDROME	0.0027132600000000003	0.135663
ACRODYSOSTOSIS	0.0027132600000000003	0.135663
DOUBLE OUTLET RIGHT VENTRICLE	0.0027132600000000003	0.135663
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0027132600000000003	0.135663
FAMILIAL INTESTINAL MALROTATION	0.0027132600000000003	0.135663
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0027132600000000003	0.135663
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0027132600000000003	0.135663
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0027132600000000003	0.135663
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0027132600000000003	0.135663
HYPERTELORISM, TEEBI TYPE; TBHS	0.0027132600000000003	0.135663
3C SYNDROME	0.0027132600000000003	0.135663
CRANIOMETAPHYSEAL DYSPLASIA	0.0027132600000000003	0.135663
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0027132600000000003	0.135663
FRASER SYNDROME	0.0027132600000000003	0.135663
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0027132600000000003	0.135663
PFEIFFER SYNDROME TYPE 2	0.0027132600000000003	0.135663
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0027132600000000003	0.135663
AUTOSOMAL DOMINANT OMODYSPLASIA	0.0027132600000000003	0.135663
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0027132600000000003	0.135663
PFEIFFER SYNDROME TYPE 1	0.0027132600000000003	0.135663
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0027132600000000003	0.135663
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0027132600000000003	0.135663
PFEIFFER SYNDROME TYPE 3	0.0027132600000000003	0.135663
CHITAYAT SYNDROME	0.0027132600000000003	0.135663
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0027132600000000003	0.135663
NOONAN SYNDROME 11; NS11	0.0027132600000000003	0.135663
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0027132600000000003	0.135663
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.0027132600000000003	0.135663
AXENFELD-RIEGER SYNDROME	0.0027132600000000003	0.135663
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0027132600000000003	0.135663
CLEIDOCRANIAL DYSPLASIA; CCD	0.0027132600000000003	0.135663
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0027132600000000003	0.135663
FETAL AKINESIA DEFORMATION SEQUENCE	0.0027132600000000003	0.135663
OTOPALATODIGITAL SYNDROME TYPE 1	0.0027132600000000003	0.135663
JOUBERT SYNDROME 32; JBTS32	0.0027132600000000003	0.135663
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.0027132600000000003	0.135663
OTOPALATODIGITAL SYNDROME TYPE 2	0.0027132600000000003	0.135663
FUMARASE DEFICIENCY; FMRD	0.0027132600000000003	0.135663
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.0027132600000000003	0.135663
HEART AND BRAIN MALFORMATION SYNDROME	0.0027132600000000003	0.135663
DIAPHANOSPONDYLODYSOSTOSIS	0.0027132600000000003	0.135663
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00246914	0.123457
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00246914	0.123457
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00246914	0.123457
CHOROIDEREMIA	0.00246914	0.123457
COWDEN SYNDROME 5; CWS5	0.00246914	0.123457
MICROCORIA, CONGENITAL	0.00246914	0.123457
COWDEN SYNDROME 6; CWS6	0.00246914	0.123457
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00246914	0.123457
%310460 MYOPIA 1, X-LINKED; MYP1	0.00246914	0.123457
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00246914	0.123457
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00246914	0.123457
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00246914	0.123457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00246914	0.123457
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00246914	0.123457
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00246914	0.123457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00246914	0.123457
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00246914	0.123457
MICROSPHEROPHAKIA WITH HERNIA	0.00246914	0.123457
USHER SYNDROME TYPE 2	0.00246914	0.123457
POLYDACTYLY-MYOPIA SYNDROME	0.00246914	0.123457
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00246914	0.123457
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00246914	0.123457
COWDEN SYNDROME	0.00246914	0.123457
PROTEUS-LIKE SYNDROME	0.00246914	0.123457
RETINITIS PIGMENTOSA 1	0.00246914	0.123457
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00246914	0.123457
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00246914	0.123457
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00246914	0.123457
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00246914	0.123457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00246914	0.123457
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00246914	0.123457
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00246914	0.123457
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00246914	0.123457
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00246914	0.123457
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00246914	0.123457
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00246914	0.123457
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00246914	0.123457
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00246914	0.123457
USHER SYNDROME	0.00246914	0.123457
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00246914	0.123457
WEILL-MARCHESANI SYNDROME 3	0.00246914	0.123457
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00246914	0.123457
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00246914	0.123457
SVEINSSON CHORIORETINAL ATROPHY	0.00246914	0.123457
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00246914	0.123457
BIOTINIDASE DEFICIENCY	0.00246914	0.123457
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00246914	0.123457
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.123457
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00246914	0.123457
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00246914	0.123457
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00246914	0.123457
BRITTLE CORNEA SYNDROME	0.00246914	0.123457
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00246914	0.123457
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00246914	0.123457
BLUE CONE MONOCHROMACY; BCM	0.00246914	0.123457
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00246914	0.123457
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00246914	0.123457
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00246914	0.123457
STICKLER SYNDROME TYPE 2	0.00246914	0.123457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00246914	0.123457
%609259 MYOPIA 10; MYP10	0.00246914	0.123457
%609258 MYOPIA 9; MYP9	0.00246914	0.123457
%609257 MYOPIA 8; MYP8	0.00246914	0.123457
%609256 MYOPIA 7; MYP7	0.00246914	0.123457
GLAUCOMA 1, OPEN ANGLE, A	0.00246914	0.123457
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00246914	0.123457
ALPORT SYNDROME, X-LINKED; ATS	0.00246914	0.123457
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00246914	0.123457
FLYNN-AIRD SYNDROME	0.00246914	0.123457
CATARACT-MICROCORNEA SYNDROME	0.00246914	0.123457
CLASSIC HOMOCYSTINURIA	0.00246914	0.123457
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246914	0.123457
RETINITIS PIGMENTOSA 75; RP75	0.00246914	0.123457
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00246914	0.123457
ÅLAND ISLANDS EYE DISEASE	0.00246914	0.123457
GLAUCOMA, PRIMARY OPEN ANGLE	0.00246914	0.123457
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00246914	0.123457
CRANIOECTODERMAL DYSPLASIA 1	0.00246914	0.123457
MYOPIA 15; MYP15	0.00246914	0.123457
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00246914	0.123457
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00246914	0.123457
SJÖGREN-LARSSON SYNDROME	0.00246914	0.123457
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00246914	0.123457
HUNTER-MACDONALD SYNDROME	0.00246914	0.123457
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00246914	0.123457
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00246914	0.123457
XP22.3 MICRODELETION SYNDROME	0.00246914	0.123457
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00246914	0.123457
MYOPIA, INFANTILE SEVERE	0.00246914	0.123457
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00246914	0.123457
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00246914	0.123457
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00246914	0.123457
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00246914	0.123457
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00246914	0.123457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.00246914	0.123457
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00246914	0.123457
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00246914	0.123457
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00246914	0.123457
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.00246914	0.123457
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00246914	0.123457
ALAND ISLAND EYE DISEASE	0.00246914	0.123457
CROUZON SYNDROME	0.00223445	0.11172249999999999
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00223445	0.11172249999999999
CHAR SYNDROME	0.00223445	0.11172249999999999
ANTLEY-BIXLER SYNDROME	0.00223445	0.11172249999999999
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00223445	0.11172249999999999
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00223445	0.11172249999999999
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00223445	0.11172249999999999
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00223445	0.11172249999999999
PELVISCAPULAR DYSPLASIA	0.00223445	0.11172249999999999
DISTAL MONOSOMY 10P	0.00223445	0.11172249999999999
ACROCALLOSAL SYNDROME; ACLS	0.00223445	0.11172249999999999
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00223445	0.11172249999999999
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00223445	0.11172249999999999
CRANIOSYNOSTOSIS 6; CRS6	0.00223445	0.11172249999999999
JACKSON-WEISS SYNDROME	0.00223445	0.11172249999999999
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00223445	0.11172249999999999
CHIME SYNDROME	0.00223445	0.11172249999999999
MARDEN-WALKER SYNDROME	0.00223445	0.11172249999999999
OROFACIODIGITAL SYNDROME IX; OFD9	0.00223445	0.11172249999999999
ACRO-RENAL-OCULAR SYNDROME	0.00223445	0.11172249999999999
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00223445	0.11172249999999999
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00223445	0.11172249999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00223445	0.11172249999999999
FRONTORHINY	0.00223445	0.11172249999999999
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00223445	0.11172249999999999
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00223445	0.11172249999999999
FREEMAN-SHELDON SYNDROME	0.00223445	0.11172249999999999
FETAL HYDANTOIN SYNDROME	0.00223445	0.11172249999999999
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00223445	0.11172249999999999
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00223445	0.11172249999999999
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00223445	0.11172249999999999
JOUBERT SYNDROME 14	0.00223445	0.11172249999999999
LAMBOTTE SYNDROME	0.00223445	0.11172249999999999
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00223445	0.11172249999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.00223445	0.11172249999999999
PENTASOMY X	0.00223445	0.11172249999999999
GORLIN SYNDROME	0.00223445	0.11172249999999999
HYPOTONIA-CYSTINURIA SYNDROME	0.00172414	0.086207
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00172414	0.086207
14Q12 MICRODELETION SYNDROME	0.00172414	0.086207
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00172414	0.086207
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00172414	0.086207
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00172414	0.086207
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00172414	0.086207
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00172414	0.086207
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00172414	0.086207
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00172414	0.086207
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00172414	0.086207
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00172414	0.086207
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00172414	0.086207
METATROPIC DYSPLASIA	0.00172414	0.086207
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00172414	0.086207
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00172414	0.086207
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00172414	0.086207
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00172414	0.086207
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00172414	0.086207
DERMOTRICHIC SYNDROME	0.00172414	0.086207
PENILE AGENESIS	0.00172414	0.086207
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00172414	0.086207
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00172414	0.086207
CODAS SYNDROME	0.00172414	0.086207
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00172414	0.086207
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00172414	0.086207
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00172414	0.086207
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00172414	0.086207
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00172414	0.086207
MENTAL RETARDATION, X-LINKED 9	0.00172414	0.086207
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00172414	0.086207
PHAVER SYNDROME	0.00172414	0.086207
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00172414	0.086207
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00172414	0.086207
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00172414	0.086207
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00172414	0.086207
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00172414	0.086207
CALVARIAL HYPEROSTOSIS	0.00172414	0.086207
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00172414	0.086207
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00172414	0.086207
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00172414	0.086207
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00172414	0.086207
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00172414	0.086207
OPSISMODYSPLASIA	0.00172414	0.086207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00172414	0.086207
OHDO SYNDROME	0.00172414	0.086207
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00172414	0.086207
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00172414	0.086207
FEINGOLD SYNDROME	0.00172414	0.086207
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00172414	0.086207
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00172414	0.086207
IMAGE SYNDROME	0.00172414	0.086207
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00172414	0.086207
GLUTAMINE DEFICIENCY, CONGENITAL	0.00172414	0.086207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00172414	0.086207
RADIO-RENAL SYNDROME	0.00172414	0.086207
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00172414	0.086207
ATELOSTEOGENESIS, TYPE II	0.00172414	0.086207
MARTSOLF SYNDROME	0.00172414	0.086207
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.00172414	0.086207
OROFACIODIGITAL SYNDROME X	0.00172414	0.086207
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00172414	0.086207
OMODYSPLASIA	0.00172414	0.086207
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00172414	0.086207
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00172414	0.086207
FACIOCARDIOMELIC SYNDROME	0.00172414	0.086207
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00172414	0.086207
SANJAD-SAKATI SYNDROME	0.00172414	0.086207
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00172414	0.086207
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00172414	0.086207
ISOTRETINOIN SYNDROME	0.00172414	0.086207
BETA-THALASSEMIA MAJOR	0.00172414	0.086207
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00172414	0.086207
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00172414	0.086207
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00172414	0.086207
ALAZAMI SYNDROME; ALAZS	0.00172414	0.086207
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00172414	0.086207
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00172414	0.086207
PALLISTER-HALL SYNDROME	0.00172414	0.086207
FETAL GAUCHER DISEASE	0.00172414	0.086207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00172414	0.086207
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00172414	0.086207
HOLOPROSENCEPHALY 3; HPE3	0.00172414	0.086207
JUBERG-MARSIDI SYNDROME	0.00172414	0.086207
HOLOPROSENCEPHALY 4	0.00172414	0.086207
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00172414	0.086207
2P21 MICRODELETION SYNDROME	0.00172414	0.086207
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00172414	0.086207
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00172414	0.086207
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.0622665
POTOCKI-SHAFFER SYNDROME	0.00124533	0.0622665
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00124533	0.0622665
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.0622665
MARINESCO-SJOGREN SYNDROME; MSS	0.00124533	0.0622665
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00124533	0.0622665
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.0622665
CHANARIN-DORFMAN SYNDROME	0.00124533	0.0622665
ABDUCENS PALSY	0.00124533	0.0622665
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.0622665
INCONTINENTIA PIGMENTI; IP	0.00124533	0.0622665
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.0622665
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.0622665
JOHANSON-BLIZZARD SYNDROME; JBS	0.00124533	0.0622665
OPTIC ATROPHY 1; OPA1	0.00124533	0.0622665
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.0622665
XERODERMA PIGMENTOSUM	0.00124533	0.0622665
SCHIZENCEPHALY	0.00124533	0.0622665
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00124533	0.0622665
AASE-SMITH SYNDROME	0.00124533	0.0622665
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.0622665
SCARF SYNDROME	0.00124533	0.0622665
RICHARDS-RUNDLE SYNDROME; RRNS	0.00124533	0.0622665
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.0622665
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.0622665
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.0622665
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.0622665
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00124533	0.0622665
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00124533	0.0622665
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.0622665
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.0622665
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.0622665
IVIC SYNDROME	0.00124533	0.0622665
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.0622665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00124533	0.0622665
COCKAYNE SYNDROME A; CSA	0.00124533	0.0622665
MEIER-GORLIN SYNDROME 1; MGORS1	0.00124533	0.0622665
MUCOLIPIDOSIS IV; ML4	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.00124533	0.0622665
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	0.0622665
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00124533	0.0622665
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00124533	0.0622665
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	0.0622665
C SYNDROME	0.00124533	0.0622665
FANCONI ANEMIA	0.00124533	0.0622665
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.0622665
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.0622665
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00124533	0.0622665
GLUTATHIONURIA	0.00124533	0.0622665
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.0622665
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.0622665
COATS DISEASE	0.00124533	0.0622665
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00124533	0.0622665
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00124533	0.0622665
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.0622665
MASA SYNDROME	0.00124533	0.0622665
HADDAD SYNDROME	0.00124533	0.0622665
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.0622665
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00124533	0.0622665
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.0622665
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.0622665
MOEBIUS SYNDROME	0.00124533	0.0622665
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.0622665
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00124533	0.0622665
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.00124533	0.0622665
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00124533	0.0622665
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.0622665
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.00124533	0.0622665
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.0622665
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.00124533	0.0622665
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.0622665
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.0622665
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.0622665
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00124533	0.0622665
JOUBERT SYNDROME 21	0.00124533	0.0622665
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0622665
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.00124533	0.0622665
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.0622665
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.0622665
EEM SYNDROME	0.00124533	0.0622665
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.0622665
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.0622665
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.0622665
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.00124533	0.0622665
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	0.0622665
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00124533	0.0622665
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.0622665
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00124533	0.0622665
FEMORAL-FACIAL SYNDROME	0.00124533	0.0622665
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.0622665
6P22 MICRODELETION SYNDROME	0.00124533	0.0622665
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00124533	0.0622665
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00124533	0.0622665
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.0622665
PONTINE TEGMENTAL CAP DYSPLASIA	0.00124533	0.0622665
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00124533	0.0622665
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.0622665
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00124533	0.0622665
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.00124533	0.0622665
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.0622665
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.00124533	0.0622665
BRANCHIO-OCULO-FACIAL SYNDROME	0.00124533	0.0622665
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.0622665
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00124533	0.0622665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.00124533	0.0622665
PROXIMAL SYMPHALANGISM	0.00124533	0.0622665
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.0622665
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.00124533	0.0622665
ATAXIA-TELANGIECTASIA	0.00124533	0.0622665
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00124533	0.0622665
FETAL IODINE SYNDROME	0.00124533	0.0622665
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.00124533	0.0622665
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00124533	0.0622665
NEONATAL ADRENOLEUKODYSTROPHY	0.00124533	0.0622665
TOLUENE EMBRYOPATHY	0.00124533	0.0622665
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00124533	0.0622665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00124533	0.0622665
BAKER-GORDON SYNDROME; BAGOS	0.00124533	0.0622665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00124533	0.0622665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00124533	0.0622665
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.0622665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00124533	0.0622665
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00124533	0.0622665
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00124533	0.0622665
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.00124533	0.0622665
JOUBERT SYNDROME 31; JBTS31	0.00124533	0.0622665
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.0622665
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00124533	0.0622665
COCKAYNE SYNDROME	0.00124533	0.0622665
IVIC SYNDROME	0.00124533	0.0622665
5Q14.3 MICRODELETION SYNDROME	0.00124533	0.0622665
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00124533	0.0622665
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0622665
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.0622665
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00124533	0.0622665
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.0622665
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00124533	0.0622665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00124533	0.0622665
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.0622665
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.0622665
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.00124533	0.0622665
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.0622665
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00124533	0.0622665
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.0622665
RAHMAN SYNDROME	0.00124533	0.0622665
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00124533	0.0622665
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	0.0622665
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.0622665
SECKEL SYNDROME 5; SCKL5	0.00124533	0.0622665
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00124533	0.0622665
GAUCHER DISEASE TYPE 2	0.00124533	0.0622665
OCULAR ALBINISM	0.00124533	0.0622665
STIFF SKIN SYNDROME	0.00124533	0.0622665
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.0622665
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.0622665
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00124533	0.0622665
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00124533	0.0622665
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.0622665
DYSEQUILIBRIUM SYNDROME	0.00124533	0.0622665
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0622665
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00124533	0.0622665
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00124533	0.0622665
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.0622665
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00124533	0.0622665
SCHINDLER DISEASE, TYPE I	0.00124533	0.0622665
GAUCHER DISEASE TYPE 3	0.00124533	0.0622665
PETERS ANOMALY	0.00124533	0.0622665
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00124533	0.0622665
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0622665
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.0622665
NANOPHTHALMOS	0.00124533	0.0622665
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.0622665
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.0622665
MORNING GLORY DISC ANOMALY	0.00124533	0.0622665
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00124533	0.0622665
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.00124533	0.0622665
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00124533	0.0622665
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.0622665
LERI PLEONOSTEOSIS	0.00124533	0.0622665
CONGENITAL RUBELLA SYNDROME	0.00124533	0.0622665
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00124533	0.0622665
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.00124533	0.0622665
WOOLLY HAIR	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.00124533	0.0622665
RETINOBLASTOMA	0.00124533	0.0622665
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.0622665
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00124533	0.0622665
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00124533	0.0622665
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.0622665
ISOLATED COMPLEX I DEFICIENCY	0.00124533	0.0622665
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.0622665
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.0622665
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.00124533	0.0622665
HADZISELIMOVIC SYNDROME	0.00124533	0.0622665
COG5-CDG	0.00124533	0.0622665
X-LINKED RETINAL DYSPLASIA	0.00124533	0.0622665
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00124533	0.0622665
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.0622665
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.0622665
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION	0.00124533	0.0622665
LINEAR VERRUCOUS NEVUS SYNDROME	0.00124533	0.0622665
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.0622665
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.0622665
2Q23.1 MICRODUPLICATION SYNDROME	0.00124533	0.0622665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00124533	0.0622665
PETERS ANOMALY	0.00124533	0.0622665
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.0622665
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.0622665
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00124533	0.0622665
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.0622665
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.0622665
NEPHRONOPHTHISIS 11; NPHP11	0.00124533	0.0622665
PRIMARY CUTIS VERTICIS GYRATA	0.00124533	0.0622665
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00124533	0.0622665
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.00124533	0.0622665
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.0622665
CAT-EYE SYNDROME	0.00098912	0.049456
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00098912	0.049456
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00098912	0.049456
FACIOCARDIORENAL SYNDROME	0.00098912	0.049456
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00098912	0.049456
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00098912	0.049456
SCHIZOPHRENIA 1; SCZD1	0.00098912	0.049456
FRONTAL ENCEPHALOCELE	0.00098912	0.049456
ISOLATED BRACHYCEPHALY	0.00098912	0.049456
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00098912	0.049456
ROIFMAN SYNDROME	0.00098912	0.049456
PHENOBARBITAL EMBRYOPATHY	0.00098912	0.049456
RENAL AGENESIS, BILATERAL	0.00098912	0.049456
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00098912	0.049456
FRONTOMETAPHYSEAL DYSPLASIA	0.00098912	0.049456
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00098912	0.049456
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00098912	0.049456
YUNIS-VARON SYNDROME	0.00098912	0.049456
ABLEPHARON-MACROSTOMIA SYNDROME	0.00098912	0.049456
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00098912	0.049456
THAKKER-DONNAI SYNDROME	0.00098912	0.049456
DYSOSTEOSCLEROSIS	0.00098912	0.049456
WIDOW'S PEAK	0.00098912	0.049456
MOSAIC TRISOMY 14	0.00098912	0.049456
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00098912	0.049456
TRIPLOIDY	0.00098912	0.049456
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00098912	0.049456
CHST3-RELATED SKELETAL DYSPLASIA	0.00098912	0.049456
FRONTONASAL DYSPLASIA 1; FND1	0.00098912	0.049456
14Q22Q23 MICRODELETION SYNDROME	0.00098912	0.049456
OSTEOGLOSPHONIC DYSPLASIA	0.00098912	0.049456
NEU-LAXOVA SYNDROME	0.00098912	0.049456
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00098912	0.049456
NEUROFACIODIGITORENAL SYNDROME	0.00098912	0.049456
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00098912	0.049456
BIFID NOSE	0.00098912	0.049456
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00098912	0.049456
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00098912	0.049456
MOSAIC TRISOMY 9	0.00098912	0.049456
OCULOTRICHOANAL SYNDROME	0.00098912	0.049456
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.00098912	0.049456
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00098912	0.049456
OPITZ G/BBB SYNDROME	0.00098912	0.049456
OROFACIODIGITAL SYNDROME TYPE 3	0.00098912	0.049456
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00098912	0.049456
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.00098912	0.049456
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.00098912	0.049456
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00098912	0.049456
OROFACIODIGITAL SYNDROME TYPE 5	0.00098912	0.049456
3MC SYNDROME	0.00098912	0.049456
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00098912	0.049456
8P23.1 DUPLICATION SYNDROME	0.00098912	0.049456
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.00098912	0.049456
HEREDITARY OROTIC ACIDURIA	0.00098912	0.049456
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00098912	0.049456
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00098912	0.049456
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00098912	0.049456
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00098912	0.049456
ACROCARDIOFACIAL SYNDROME	0.00098912	0.049456
GENITOPALATOCARDIAC SYNDROME	0.00098912	0.049456
CUTIS LAXA	0.00098912	0.049456
HALL-RIGGS SYNDROME	0.00098912	0.049456
THOMAS SYNDROME	0.00098912	0.049456
OROFACIODIGITAL SYNDROME V; OFD5	0.00098912	0.049456
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00098912	0.049456
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00098912	0.049456
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00098912	0.049456
17P13.3 MICRODUPLICATION SYNDROME	0.00098912	0.049456
ACROCEPHALOPOLYDACTYLY	0.00098912	0.049456
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00098912	0.049456
CENANI-LENZ SYNDROME	0.00098912	0.049456
JUBERG-HAYWARD SYNDROME	0.00098912	0.049456
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00098912	0.049456
ALG13-CDG	0.00098912	0.049456
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00098912	0.049456
TRISOMY 9P	0.00098912	0.049456
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00098912	0.049456
LAURIN-SANDROW SYNDROME	0.00098912	0.049456
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00098912	0.049456
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00098912	0.049456
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00098912	0.049456
FRONTONASAL DYSPLASIA	0.00098912	0.049456
HYPERTELORISM	0.00098912	0.049456
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00098912	0.049456
6Q25 MICRODELETION SYNDROME	0.00098912	0.049456
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00098912	0.049456
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00098912	0.049456
OCULOCEREBROCUTANEOUS SYNDROME	0.00098912	0.049456
RHOMBENCEPHALOSYNAPSIS	0.00098912	0.049456
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00098912	0.049456
DIAMOND-BLACKFAN ANEMIA 8	0.00098912	0.049456
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00098912	0.049456
WHITE FORELOCK WITH MALFORMATIONS	0.00098912	0.049456
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00098912	0.049456
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00098912	0.049456
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00098912	0.049456
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00098912	0.049456
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00098912	0.049456
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00098912	0.049456
CHROMOSOME 4Q21 DELETION SYNDROME	0.00098912	0.049456
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00098912	0.049456
TEEBI-SHALTOUT SYNDROME; TBSH	0.00098912	0.049456
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00098912	0.049456
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00098912	0.049456
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00098912	0.049456
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00098912	0.049456
ROBERTS SYNDROME; RBS	0.00098912	0.049456
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00098912	0.049456
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00098912	0.049456
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00098912	0.049456
MECKEL SYNDROME	0.00098912	0.049456
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00098912	0.049456
TRICHOHEPATOENTERIC SYNDROME 2	0.00098912	0.049456
BARTSOCAS-PAPAS SYNDROME; BPS	0.00098912	0.049456
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00098912	0.049456
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00098912	0.049456
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00098912	0.049456
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00098912	0.049456
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00098912	0.049456
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00098912	0.049456
DIAMOND-BLACKFAN ANEMIA 5	0.00098912	0.049456
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00098912	0.049456
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00098912	0.049456
MESOMELIA-SYNOSTOSES SYNDROME	0.00098912	0.049456
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00098912	0.049456
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00098912	0.049456
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00098912	0.049456
CRANIOSYNOSTOSIS 4; CRS4	0.00098912	0.049456
TARP SYNDROME; TARPS	0.00098912	0.049456
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00098912	0.049456
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00098912	0.049456
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00098912	0.049456
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00098912	0.049456
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00098912	0.049456
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00098912	0.049456
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00098912	0.049456
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00098912	0.049456
NOONAN SYNDROME 2; NS2	0.00098912	0.049456
CEREBROOCULONASAL SYNDROME	0.00098912	0.049456
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00098912	0.049456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00098912	0.049456
KEIPERT SYNDROME; KPTS	0.00098912	0.049456
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00098912	0.049456
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.00098912	0.049456
%608572 BURN-MCKEOWN SYNDROME	0.00098912	0.049456
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00098912	0.049456
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00098912	0.049456
FRIAS SYNDROME	0.00098912	0.049456
NOONAN SYNDROME 3; NS3	0.00098912	0.049456
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00098912	0.049456
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.00098912	0.049456
PALLISTER-HALL SYNDROME	0.00098912	0.049456
STEEL SYNDROME; STLS	0.00098912	0.049456
OROFACIODIGITAL SYNDROME IV; OFD4	0.00098912	0.049456
OROFACIODIGITAL SYNDROME III	0.00098912	0.049456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00098912	0.049456
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00098912	0.049456
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00098912	0.049456
ANOPHTHALMIA PLUS SYNDROME	0.00098912	0.049456
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00098912	0.049456
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00098912	0.049456
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00098912	0.049456
ATELOSTEOGENESIS TYPE I	0.00098912	0.049456
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00098912	0.049456
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00098912	0.049456
ASCHER SYNDROME	0.00098912	0.049456
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00098912	0.049456
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00098912	0.049456
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00098912	0.049456
CHARLIE M SYNDROME	0.00098912	0.049456
RING CHROMOSOME 10 SYNDROME	0.00098912	0.049456
RING CHROMOSOME 6 SYNDROME	0.00098912	0.049456
TRICHOHEPATOENTERIC SYNDROME 1	0.00098912	0.049456
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00098912	0.049456
VICI SYNDROME	0.00098912	0.049456
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.00098912	0.049456
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00098912	0.049456
MONOSOMY 13Q14	0.00098912	0.049456
DISTAL MONOSOMY 13Q	0.00098912	0.049456
ACALVARIA	0.00098912	0.049456
3Q13 MICRODELETION SYNDROME	0.00098912	0.049456
ACROCALLOSAL SYNDROME	0.00098912	0.049456
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00098912	0.049456
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00098912	0.049456
DISTAL MONOSOMY 9P	0.00098912	0.049456
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00098912	0.049456
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00098912	0.049456
NOONAN SYNDROME 8; NS8	0.00098912	0.049456
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.00098912	0.049456
HARTSFIELD SYNDROME; HRTFDS	0.00098912	0.049456
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00098912	0.049456
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00098912	0.049456
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00098912	0.049456
NEMALINE MYOPATHY 2; NEM2	0.00098912	0.049456
NEU-LAXOVA SYNDROME 2; NLS2	0.00098912	0.049456
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00098912	0.049456
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00098912	0.049456
NOONAN SYNDROME 9; NS9	0.00098912	0.049456
NOONAN SYNDROME 10; NS10	0.00098912	0.049456
JOUBERT SYNDROME 26	0.00098912	0.049456
OROFACIAL CLEFT 15	0.00098912	0.049456
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00098912	0.049456
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.00098912	0.049456
MECKEL SYNDROME, TYPE 1; MKS1	0.00098912	0.049456
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00098912	0.049456
3MC SYNDROME 3	0.00098912	0.049456
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00098912	0.049456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00098912	0.049456
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00098912	0.049456
STROMME SYNDROME; STROMS	0.00098912	0.049456
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00098912	0.049456
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00098912	0.049456
VICI SYNDROME; VICIS	0.00098912	0.049456
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00098912	0.049456
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00098912	0.049456
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00098912	0.049456
POSTERIOR URETHRAL VALVE	0.00098912	0.049456
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00098912	0.049456
ISOLATED ARRHINIA	0.00098912	0.049456
